Molecular and Functional Characterization of Programmed Cell Death (PCD) in Toxoplasma gondii by Ni Nyoman, Ayu Dewi
 
Molecular and Functional Characterization of  






for the award of the degree 
  "Doctor rerum naturalium" (Dr.rer.nat.)   
of the Georg-August-Universität Göttingen 
within the doctoral program Biology 






Ni Nyoman Ayu Dewi 
from Denpasar, Indonesia (born on 10
th








1. Prof. Dr. Uwe Groß 
    (Institute for Medical Microbiology, Department of Medical Microbiology) 
2. Prof. Dr. Ernst A. Wimmer 
    (Johann-Friedrich-Blumenbach-Institute of Zoology and Anthropology, Department of  
    Developmental Biology) 
 
Supervisor 
Prof. Dr. Carsten G.K. Lüder 
(Institute for Medical Microbiology, Department of Medical Microbiology) 
 
Members of the Examination Board 
Reviewer:  Prof. Dr. Uwe Groß 
            (Institute for Medical Microbiology, Department of Medical Microbiology) 
Second reviewer: Prof. Dr. Ernst A. Wimmer 
(Johann-Friedrich-Blumenbach-Institute of Zoology and Anthropology, 
Department of Developmental Biology) 
 
Further members of the Examination Board: 
1. Prof. Dr. Stefanie Pöggeler  
 (Department of Genetics of Eukaryotic Microorganisms) 
2. Prof. Dr. Rolf Daniel 
 (Department of Genomic and Applied Microbiology) 
3. Prof. Dr. Sigrid Hoyer-Fender 
 (Johann-Friedrich-Blumenbach-Institute of Zoology and Anthropology, Department of 
Developmental Biology) 
4. PD Dr. Stefan Irniger 




Date of the oral examination: 16
th































Printing cost is kindly covered by German Academic Exchange Service/Deutscher 

































I hereby declare that this submission entitled ―Molecular and Functional Characterization 
of Programmed Cell Death (PCD) in Toxoplasma gondii― is my own work and that, to the 
best of my knowledge and belief, it contains no material previously published or written by 
another person nor material which to a substantial extent has been accepted for the award 





 March 2013 
 
Ni Nyoman Ayu Dewi 
 




Doing experiments are never solitary efforts; therefore I would like to thank everyone who 
helped in the completion of this project. 
I would like to acknowledge and extend my heartfelt gratitude to Prof. Uwe Groß for 
giving me the opportunity to work in the Insitute for Medical Microbiology, for accepting 
to be my first referee for my PhD thesis, for his guidance and constructive advices during 
my doctoral study. 
I would like to express my deep gratitude to Prof. Carsten G.K. Lüder for allowing me to 
work in his group, for designing a very intriguing and challenging project, and for 
invaluable discussion, critical advices, encouragement and limitless support throughout my 
study. He never accepted less than my best efforts. 
I would like to thank Prof. Ernst A. Wimmer for accepting to be the second referee for my 
PhD thesis and for his critical advices. 
I would like also to thank Prof. Stefanie Pöggeler, Prof. Rolf Daniel, Prof. Sigrid Hoyer-
Fender, and PD Dr. Stefan Irniger for agreeing to be members of the examination 
committee for my PhD disputation.  
My special thanks go to Prof. Antonio Jiménez-Ruiz (Madrid) for cooperation in providing 
information on the structure of TgEndoG and for invaluable discussion, Prof. Dominique 
Soldati-Favre (Geneva) for providing plasmids containing T. gondii Bax inhibitors 
sequences and Prof. Dirk Schlüter (Magdeburg) for providing T. gondii tissue cysts to 
develop chronic infection in mice. 
I would like to express my gratitude to Dr. Wolfgang Bohne and Martin Thiele for their 
collaboration and great assistance on generation of YFP-tagging TgEndoG and also for 
sharing experiences and stimulating discussion. 
 
Page | iii  
 
I would like to express my special gratitude to the German Academic Exchange Service 
(DAAD) for the financial and non-financial support during my study and also to Ms Nina 
Giebel (International Students Advisor) for her guidance and great assistance on 
administrative procedures throughout my academic program. 
To COST Action BM0802 ―Life and death of protozoan parasites‖, I would like to thank 
for giving me grants to attend bioinformatics workshop and several scientific meetings 
abroad; I met many experts who are working on parasites and cell death and I have had  
very interesting discussions with them. 
Many thanks are expressed to my colleagues in Department of Biochemistry Faculty of 
Medicine, Udayana University, especially to Desak Made Wihandani for her motivation, 
support and assistance with many bureaucratic procedures.  
Special thanks are given to all people in the laboratory. I would like to thank Dr. Raimond 
Lugert and Dr. Oliver Bader for stimulating discussion. Thanks to Anna, Kristin, San San, 
Malik, Ichsan and Andrea for being my friends and for all supports. Most especially to 
Izabela, Jana, Marut, and Maisalreem for telling me things that I do not want to tell myself. 
And also many thanks to Julia, Maiko and Florian, students who performed lab rotation 
and helped me to work on T. gondii Bax inhibitors. 
Last but not least, most especially, I owe my deepest gratitude to my parents who passed 
away during my doctoral study period, to my superb husband Aryana Mahayasa and my 
little princess Ayulia for their limitless support and encouragement, and to whole my 
family, especially my parents-in-law, for their great support and motivation. Words alone 
cannot express what I owe them for their encouragement and love. To all of them, I 
dedicate my work with respect and gratitude. 
 
Page | iv  
 





Table of contents iv 
List of Figures  x 
List of Tables xii 
List of Abbreviations xiii 
 
CHAPTER 1   INTRODUCTION 
1.1. Toxoplasma gondii  1 
1.1.1. A brief history 1 
1.1.2. Medical importance and therapy 1 
1.1.3. Morphology of T. gondii 2 
1.1.4. Life cycle and transmission of T. gondii infection 4 
1.1.5. Genetics of T. gondii 6 
  
1.2. Programmed cell death (PCD)  
1.2.1. Classification of cell death 7 
1.2.2. Apoptosis in multicellular organisms 10 
1.2.3. Apoptosis-like cell death in unicellular organisms 12 
  
1.3. Objectives of the study 14 
 
CHAPTER 2   MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Cell lines, T. gondii and bacteria strains 16 
2.1.2. Cell death inducers 16 
2.1.3. Antibiotics and parasiticidal agents  17 
2.1.4. Protease substrate and protease inhibitors 17 
 
Page | v  
 
2.1.5. Antibodies 18 
2.1.6. Fluorescent probes 18 
2.1.7. Oligonucleotides 18 
2.1.8. Plasmids 20 
2.1.9. Molecular weight markers 20 
2.1.10. Enzymes 21 
2.1.11. Kits 21 
2.1.12. Other chemicals and reagents 21 
2.1.13. Instruments 22 
  
2.2. Methods 
2.2.1. Maintenance of cells and cell harvest  
2.2.1.1. In vitro cultivation of Toxoplasma gondii 23 
2.2.1.2. Production of brain cysts 24 
2.2.1.3. Cultivation of wild type and transfected cell lines 24 
2.2.1.4. Harvesting of T. gondii tachyzoites 25 
2.2.1.5. Harvesting mammalian cells 25 
2.2.1.6. Cell count 25 
2.2.1.7. Cryopreservation of cells 25 
2.2.2. Determination of apoptosis markers   
2.2.2.1. DNA strand breaks and cell size reduction in extracellular parasites 26 
2.2.2.2. DNA strand breaks in intracellular parasites 27 
2.2.2.3. Detection of phosphatidylserine exposure 28 
2.2.2.4. Effect of pro-apoptotic stimuli on parasite invasiveness 28 
2.2.3. Physiological significance of apoptosis-like cell death in T. gondii  
2.2.3.1. TUNEL staining of T. gondii from the peritoneal cavity during acute 
toxoplasmosis in mice 
29 
2.2.3.2. TUNEL staining of brain cysts from chronically infected mice 29 







Page | vi  
 
2.2.4. Putative regulators of apoptosis-like cell death in T. gondii  
2.2.4.1. RNA isolation and cDNA synthesis 30 
2.2.4.2. Primer design and quantitative real-time PCR  31 
2.2.4.3. Heterologous expression of Toxoplasma gondii Bax inhibitors (TgBIs)  
2.2.4.3.1. Transfection of TgBIs-coding genes into HeLa cells 31 
2.2.4.3.2. Indirect immunofluorescence assay 33 
2.2.4.3.3. Colocalisation of TgBIs 33 
2.2.4.3.4. Measurement of caspase 3/7 activity  34 
2.2.4.3.5. Quantification of protein concentration  35 
2.2.4.3.6. Analysis of hypoploid DNA  35 
2.2.4.3.7. Redistribution of TgBIs during cell death induction in transgenic HeLa 
cells 
36 
2.2.4.4. Putative T. gondii Endonuclease G (TgEndoG)  
2.2.4.4.1. Cloning procedure 36 
2.2.4.4.1.1. Digestion of plasmid or PCR products 36 
2.2.4.4.1.2. Analysing DNA fragments by agarose gel electrophoresis 37 
2.2.4.4.1.3. DNA extraction from agarose gels 37 
2.2.4.4.1.4. Vector dephosphorylation 38 
2.2.4.4.1.5. Ligation 38 
2.2.4.4.1.6. Transformation 38 
2.2.4.4.1.7. Screening transformants 39 
2.2.4.4.1.8. Plasmid extraction 39 
2.2.4.4.1.9. Preparation of glycerol stocks of bacteria 40 
2.2.4.4.2. Protein expression 40 
2.2.4.4.3. Analysis of protein expression   
2.2.4.4.3.1. Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
40 
2.2.4.4.3.2. Coomassie blue staining of proteins separated by SDS-PAGE 41 
2.2.4.4.3.3. Electroblotting of proteins separated by SDS-PAGE 42 
2.2.4.4.3.4. Blocking, washing and antibody incubation 42 
2.2.4.4.3.5. Protein detection 44 
2.2.5. Regulation of Toxoplasma PCD  
2.2.5.1.  Detection of ΔΨm 44 
 
Page | vii  
 
2.2.5.2. In situ measurement of caspase-like activity 44 
2.2.5.3. Impact of proteases during induction of apoptosis-like cell death in T. 
gondii 
45 
2.2.6. Bioinformatics 46 
2.2.7. Statistical analysis 46 
  
CHAPTER 3  RESULTS 
3.1. Toxoplasma gondii exhibited markers of apoptosis in response to pro-apoptotic 
stimuli  
3.1.1. The occurrence of DNA fragmentation in T. gondii after stimulation of 
cell death 
47 
3.1.2. Cell size reduction in extracellular parasites after treatment with pro-
apoptotic stimuli 
50 
3.1.3. Treatment with staurosporine, but not HePC, triggered TUNEL-positivity 
in intracellular parasites  
52 
3.1.4. T. gondii displayed phosphatidylserine externalization following 
treatment with pro-apoptotic stimuli 
53 
3.1.5. Pre-treatment of extracellular parasites with pro-apoptotic stimuli 
diminished parasite invasion 
55 
  
3.2. Physiological significance of apoptosis-like cell death in T. gondii 
3.2.1. TUNEL- positive parasites were observed during chronic infection with 
T. gondii, but not during acute infection 
57 
3.2.2. An apoptosis-like cell death occurred after treatment of tachyzoites with 
chemotherapeutic drugs commonly used against toxoplasmosis 
59 
 
3.3.  Molecules that may be responsible for the regulation of apoptosis-like cell death 
in T. gondii  
3.3.1. Up-regulation of cell death-associated genes following treatment of T. 
gondii with pro-apoptotic stimuli 
61 
3.3.2. Toxoplasma gondii Bax inhibitors (TgBIs)  
 
Page | viii  
 
3.3.2.1. Bioinformatic analysis 64 
3.3.2.2. Immunofluorescence assay of T. gondii Bax inhibitors demonstrated  
distinct localisations of the proteins 
66 
3.3.2.3. TgBIs showed a non-mitochondrial localisation  67 
3.3.2.4. Redistribution of TgBIs upon cell death induction 69 
3.3.2.5. TgBIs in HeLa cells partially inhibited caspase 3/7 activity following 
cell death induction 
70 
3.3.2.6. TgBIs in HeLa cells reduced the induction of hypoploid DNA 
following pro-apoptotic treatments 
72 
3.3.3. Toxoplasma gondii Endonuclease G (TgEndoG)  
3.3.3.1. Bioinformatic analysis 73 
3.3.3.2. T. gondii Endonuclease G had a non-mitochondrial localisation 75 
3.3.3.3. Cloning and expression T. gondii Endonuclease G 76 
  
3.4. Regulation of apoptosis-like cell death in T. gondii 
3.4.1. Disruption of mitochondrial membrane potential following treatment of 
extracellular parasites with pro-apoptotic stimuli 
78 
3.4.2. Activation of caspase-like proteases was detected in T. gondii after 
treatment with pro-apoptotic stimuli 
79 




CHAPTER 4  DISCUSSION 
4.1. Cell death markers identified in T. gondii are characteristic for apoptosis in 
metazoans 
82 
4.2. Possible benefits of an apoptosis-like cell death in T. gondii 84 
4.3. Identification of putative regulators of an apoptosis-like cell death in T. 
gondii  
86 




Page | ix  
 





Curriculum vitae 110 
 
Page | x  
 
List of Figures 
 
CHAPTER 1  INTRODUCTION 
Figure 1.1. Schematic structure of tachyzoites and bradyzoites of  Toxoplasma 
gondii 
3 
Figure 1.2. Life cycle of Toxoplasma gondii 5 
Figure 1.3. Genomes of Toxoplasma gondii 6 
Figure 1.4. Apoptosis pathways in mammalian cells 11 
 
CHAPTER 3  RESULTS 
Figure 3.1. DNA fragmentation in extracellular parasites following treatment with 
pro-apoptotic stimuli was detected by TUNEL assay followed by flow 
cytometry 
49 
Figure 3.2. Kinetics of DNA fragmentation in T. gondii upon cell death induction 
by staurosporine or miltefosine as detected by TUNEL assay and flow 
cytometry 
50 
Figure 3.3. Reduction of the parasite cell size and alterations of the morphology of 
T. gondii following treatment with pro-apoptotic stimuli were assessed 
by flow cytometry and immunofluorescence microscopy 
51 
Figure 3.4. DNA fragmentation in intracellular parasites after treatment with 
staurosporine 
53 
Figure 3.5. Translocation of phosphatidylserine (PS) after staurosporine or 
miltefosine treatment 
54 
Figure 3.6. Pre-treatment of extracellular parasites with pro-apoptotic stimuli 
abrogate the ability of T. gondii to invade HFF cells 
56 
Figure 3.7. TUNEL-positive bradyzoites were detected during chronic infection of 
T. gondii 
58 
Figure 3.8. Induction of an apoptosis-like cell death in extracellular and 




Page | xi  
 
Figure 3.9. Transcript levels of T. gondii putative PCD-associated genes after 
treatment of parasites with pro-apoptotic stimuli 
64 
Figure 3.10. Expression and localisation of TgBIs in HeLa cells was detected by 
immunofluorescence microscopy 
67 
Figure 3.11. Heterologous expression of TgBIs showed a non-mitochondrial 
localisation as detected by MitoTracker and anti-FLAG co-staining 
68 
Figure 3.12. Redistribution of TgBI-2 and TgBI-3 following staurosporine or 
brefeldin A treatment 
70 
Figure 3.13. Measurement of caspase 3/7 activity partially revealed an inhibitory 
effect of TgBI-1 and TgBI-2 in HeLa cells, but not TgBI-3, on 
apoptosis induction in HeLa cells after treatment with staurosporine 
and brefeldin A 
71 
Figure 3.14. Inhibition of hypoploid nuclei by TgBIs upon cell death stimulation in 
HeLa cells 
73 
Figure 3.15. Alignment of EndoG sequences from different species and prediction 
of TgEndoG structure 
74 
Figure 3.16. YFP-tagging of endogenous TgEndoG demonstrated that TgEndoG 
has a non-mitochondrial localisation 
75 
Figure 3.17. Recombinant plasmid construct of pASK-IBA3plus containing 
TgEndoG coding sequence and heterologous expression of the fusion 
protein as detected by immunoblotting 
77 
Figure 3.18. Dissipation of mitochondrial membrane potential after treatment of 
extracellular parasites with pro-apoptotic stimuli 
79 
Figure 3.19. Caspase-like proteases were activated in T. gondii following pro-
apoptotic treatment 
80 
Figure 3.20. DNA strand breaks in T. gondii after treatment with miltefosine was 
inhibited by the presence of protease inhibitors 
81 
 
Page | xii  
 
List of Tables 
 
 
CHAPTER 1   INTRODUCTION 
Table 1.1.  Classification of cell death modalities 9 
 
CHAPTER 2   MATERIAL AND METHODS 
Table 2.1. Cell death inducers and concentrations used in this study 16 
Table 2.2. Antibiotics and antiparasite drugs and concentrations used in this 
study 
17 
Table 2.3. Protease substrate and protease inhibitors and concentrations 
used in this study 
17 
Table 2.4. Antibodies used for Western Blot (WB) or immunofluorescence 
assay (IFA) and concentrations used in this study 
18 
Table 2.5. Primer pairs for amplifying cell death-related genes via 
quantitative real time PCR 
19 




CHAPTER 3   RESULTS 
 
Table 3.1.  Toxoplasma gondii cell death-associated genes 61 
Table 3.2. Characteristic of TgBIs  65 
 
CHAPTER 4   DISCUSSION 
 
Table 4.1. Regulation of an apoptosis-like cell death in T. gondii following  
                 staurosporine and miltefosine treatment 
93 
 
Page | xiii  
 
List of Abbreviations 
 
 
AIDS   Acquired immunodeficiency syndrome 
AIF   Apoptosis-inducing factor 
APS    Ammonium persulfate 
ATc   Anhydrotetracycline 
Bcl   B-cell lymphoma 
BI-1   Bax inhibitor-1 
BLAST   Basic local alignment search tool 
BSA    Bovine serum albumin 
cDNA    Complementary DNA 
ddHB2BO   Double distilled water 
ΔΨm   Mitochondrial membrane potential  
DEVD-AMC  Asp-Glu-Val-Asp-Aminomethylcoumarin 
DMEM    Dulbecco's modified eagle medium 
DMSO   Dimethyl sulfoxide 
DNA    Deoxyribonucleic acid 
dNTP    Dinucleotide phosphate 
DTT    1,4-Dithiothreitol 
ECL    Enhanced chemiluminescent detection 
E. coli   Escherichia coli 
EDTA   Ethylene diamine tetraacetic acid 
EndoG   Endonuclease G 
ER   Endoplasmic reticulum 
E64   trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane 
FACS   Fluorescence activated cell sorting 
FCS    Fetal calf serum 
g    Force of gravity 
h   Hour(s) 
HePC   Hexadecylphosphorylcholine (miltefosine) 
HFF    Human foreskin fibroblast 
HRP   Horseradish peroxidase 
 
Page | xiv  
 
IFA    Immunoflurescence assay 
IgG    Immunoglobulin G 
IPTG    Isopropyl beta-D-thiogalactopyranoside 
kb    Kilo base pair 
kDa    Kilo Dalton 
LB    Luria Broth 
M    Molar 
ml    Milliliter 
min    Minute 
mg    Milligram 
μg    Microgram 
μl    Microliter 
μm    Micrometer 
MOMP  Mitochondrial outer membrane permeabilisation 
mRNA   Messenger RNA 
NEAA   Non-essential amino acid 
nM   nanoMolar 
p    P value 
PAGE    Polyacrylamide gel electrophoresis 
PBS    Phosphate buffered saline 
PCD   Programmed cell death 
PCR    Polymerase chain reaction 
PE   Phycoerythine 
PV   Parasitophorous vacuole 
RNA    Ribonucleic acid 
RNase   Ribonuclease 
rpm    Revolutions per minute 
RPMI    Roswell Park Memorial Institute  
RT    Room temperature 
RT-PCR   Reverse transcription-polymerase chain reaction 
sec    Second 
SDS    Sodium dodecyl sulphate 
SEM   Standard error of the mean 
 
Page | xv  
 
7-AAD  7-Amino-Actinomycin D 
Stau   Staurosporine 
tet    Tetracycline 
Tg    T. gondii 
Tm    Annealing temperature 
Tris   Tris(hydroxylmethyl)-aminomethan 
tRNA   transfer RNA 
TUNEL   Terminal deoxynucleotidyl transferase-mediated X-dUTP nick end  
   labelling 
U    Unit 
UV    Ultraviolet 
V    Voltage 
v    Volume 
w    Weight 
WB    Western blot 
WT   Wildtype 
YFP   Yellow fluorescence protein 
Z-VAD-FMK  z-Val-Ala-Asp-fluoromethylketone 
 
 
Chapter 1 Introduction 
 





1.1. Toxoplasma gondii 
1.1.1. A brief history  
Nicolle and Manceaux, scientists who were working in North Africa, 
unintentionally discovered a protozoan in tissues of a hamster-like rodent, Ctenodactilus 
gundi, in 1908. The parasite was later named Toxoplasma gondii based on the morphology 
and the host (in Greek: toxo = arc or bow, plasma = life). Another scientist in Brazil, 
Alfonso Splendore, also discovered the same parasite in a rabbit in 1908 (Dubey, 2008; 
Innes, 2010). However, it took then 60 years to unravel the complex life cycle of T. gondii 
(Frenkel et al., 1970). 
Toxoplasma gondii is an obligate intracellular protozoan parasite and can infect all 
warm-blooded animals including humans (Innes, 2010). It belongs to the phylum 
Apicomplexa that consist of more than 5000 species of parasitic protozoa. Many 
apicomplexan parasites are important pathogens of humans and animals including 
Plasmodium (responsible for malaria), Eimeria (a poultry and cattle pathogen), Neospora 
(a pathogen of dogs and cattle), Cryptosporidium (an opportunistic human and animal 
pathogen, devastating for AIDS patients), Babesia and Theileria (cattle parasites) (Hu et 
al., 2004; Saeij et al., 2005).  
 
1.1.2. Medical importance and therapy 
Toxoplasma gondii infection is highly prevalent in humans and animals worldwide 
with varying prevalence in different geographic areas (Dubey, 1998; Hill and Dubey, 
2002). For example, in the United States and the United Kingdom, an estimated 16 to 40 % 
of the population is infected. In Central and South America and parts of Europe, 50 to 80 
% of humans are estimated to be infected (Hill and Dubey, 2002). Infection of T. gondii is 
typically asymptomatic; however it may lead to severe symptoms or be even fatal (death) 
in individuals with immune dysfunction, e.g. AIDS patients and in developing foetuses and 
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neonates. Additionally, this parasite was more recently found to be related with severe 
intraocular inflammation after infection of immunocompetent adults (Innes, 2010).  
Several chemotherapeutic drugs are available to treat symptomatic toxoplasmosis 
or to prevent the development of clinical manifestation. A drug regimen that is widely used 
up to now for treating toxoplasmosis is a combination of sulphadiazine, pyrimethamine 
and folinic acid (Montoya and Remington, 2008). Other drugs that are also commonly used 
include atovaquone, spiramycin, clindamycin, or diaminodiphenylsulphone (Hill and 
Dubey, 2002). However, drugs currently available are not effective to eradicate the 
parasite, particularly the persistent bradyzoite stage. Instead, they only target the tachyzoite 
stage of T. gondii, which is however responsible for the clinical symptoms during acute 
toxoplasmosis. Side effects of the drugs have been also reported; for instance, spiramycin 
has a teratogenic effect and thus can not be used to treat toxoplasmosis during pregnancy 
(Montoya and Remington, 2008). Therefore, new approaches to design novel drugs to 
eradicate T. gondii are required.  
 
1.1.3. Morphology of T. gondii 
Toxoplasma gondii has three infectious stages: tachyzoites, bradyzoites, and 
sporozoites (Dubey et al., 1998).  
The tachyzoite is the rapidly multiplying intracellular stage which is associated 
with acute infection. The term tachyzoite was invented by Frenkel in 1973 (tachos = speed 
in Greek).  Before that, this stage was called trophozoite or endozoite. It has a crescent 
shape, approximately 2 by 6 µm, with a pointed anterior (conoidal) end and a rounded 
posterior end (Figure 1.1). The shape of tachyzoites becomes ovoid after they enter the 
host cells by actively penetrating through the host cell plasma membrane. Within the host 
cells, tachyzoites are enclosed within a parasitophorous vacuole (PV), the membrane of 
which is formed by both the parasite and the host cell. Tachyzoites multiply asexually 
within the host cell by endodyogeny until the host cell ruptures because it can no longer 
support the growth of tachyzoites. After dissemination within their hosts, tachyzoites 
differentiate into bradyzoites in the brain, muscles, and other organs, where they may 
remain latent for the host‘s life (Dubey et al., 1998; Dzierszinski et al., 2004). 
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The bradyzoite, a slowly growing parasite stage (brady = slow), is the stage present 
in tissue cysts. Bradyzoites are also named cystozoites (Dubey, 2008; Dubey et al., 1998; 
Weiss and Kim, 2000). Bradyzoites divide by endodyogeny in tissue cysts and also remain 
intracellular. The size of tissue cysts is variable; young tissue cysts may contain only two 
bradyzoites and the diameter may be as small as 5 µm, while older cysts may contain 
hundreds of bradyzoites. The crescent-shaped bradyzoite has approximately 7 by 1.5 µm in 
size (Figure 1.1) (Dubey et al., 1998).  
 
Figure 1.1. Schematic structure of tachyzoites (left) and bradyzoites (right) of Toxoplasma gondii. 
Tachyzoites and bradyzoites of T. gondii are structurally similar, however they vary in certain organelles and 
inclusion bodies. For instance, the nucleus of tachyzoites is located in the centre of the parasite while in 
bradyzoites, the nucleus is situated towards the posterior end (Dubey et al., 1998). Picture is taken from 
Dubey et al. (1998), p. 269. 
 
Oocysts are only shed by the definitive hosts, i.e. members of the Felidae, 
particularly the cat, after ingesting any of the three infectious stages. The shortest prepatent 
period, i.e. the time from infection until the shedding of oocysts, is after ingestion of tissue 
cysts (3 to 10 days). The prepatent period is 13 days or more after consuming tachyzoites 
and 18 days or more after oocysts ingestion (Dubey, 2008; Dubey et al., 1998). Almost all 
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cats shed oocysts after tissue cysts ingestion whereas less than 30-50 % of cats shed 
oocysts after ingestion of tachyzoites or oocysts (Dubey, 2009; Dubey et al., 1998). 
Unsporulated oocyts are 10 by 12 µm in diameter and have a subspheric to spheric shape. 
Sporulation occurs in the environment after 1 to 5 days of excretion, depending on aeration 
and temperature. Sporulated oocysts are subspheric to ellipsoid, 11 by 13 µm in diameter. 
Each oocyst contains 2 ellipsoidal sporocysts; each sporocyst is 6 by 8 µm in size and 
contains 4 sporozoites. Sporozoites are morphologically similar with tachyzoites with a 
size of 2 by 6 to 8 µm and have a subterminal nucleus (Dubey et al., 1998). 
 
1.1.4. Life cycle and transmission of T. gondii infection 
Toxoplasma gondii has a complex life cycle; it consists of a sexual cycle in its 
definitive hosts and asexual cycles both in its definitive and intermediate hosts (including 
humans) (Figure 1.2). So far, the development of T. gondii in cats has only been studied in 
detail following ingestion of tissue cysts (Dubey, 1998). After ingestion of tissue cysts, the 
cyst wall is digested and bradyzoites are released into the intestinal lumen and then cross 
the intestinal wall. The parasites replicate throughout the body as rapidly dividing 
tachyzoites (extra-intestinal cycle). Simultaneously, the organisms invade and replicate 
within the intestinal epithelial cells (entero-epithelial cycle). During the entero-epithelial 
cycle, five distinct morphological asexual types (A-E) are formed in the enterocytes of 
cats, leading to a sexual cycle (which only occurs in the definitive host) and finally 
resulting in the production of oocysts (Dubey, 1998; Dubey et al., 1998). Oocysts are 
secreted within the cats‘ feces into the environment, where they undergo sporulation and 
contaminate food, water and soil.  As the cat develops an immune response, cats stop 
shedding oocyst and the development of tachyzoites is also halted. Bradyzoites (slowly 
replicating forms of the organism) within tissue cysts are subsequently formed. Cats 
continue shedding million of oocysts for 1-2 weeks. Once cats develop an immune 
response to T. gondii, reshedding of oocysts is extremely rare (Dubey, 1995). 
Intermediate hosts can be infected by the ingestion of sporulated oocysts. As in the 
cats, parasites undergo an extra-intestinal cycle (asexual reproduction). Subsequent 
immune response leads to the development of encysted bradyzoites which may persist for 
years (potentially for the host‘s lifetime), mainly in the nervous system, muscles and heart 
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tissue (Dubey et al., 1998). The tissue cysts containing bradyzoites are infectious to cats 
and also to other intermediate hosts (Innes, 2010). Therefore, a regular transmission route 
is also via ingestion of tissue cysts in infected undercooked or cured meat. 
 
Figure 1.2. Life cycle of Toxoplasma gondii. 
T. gondii undergoes its sexual cycle only in the intestine of Felidae, mostly cats (definitive host). The 
definitive host shed oocysts that undergo sporogony in the environment to generate sporozoites. Oocysts are 
environmentally resistant and can infect a variety of intermediate hosts. Acute infection is characterised by 
dissemination of tachyzoites within the host. Primary infection in pregnant women can lead to transmission 
of infection to the foetus, possibly resulting in miscarriage or severe birth defects. Tissue cysts harbouring 
bradyzoites are responsible for long-term infection and are transmitted following oral ingestion by 
intermediate hosts (Dubey et al., 1998; Sibley et al., 2009). Picture is taken from Dubey et al. (1998), p. 268. 
  
Additionally, transmission of infection may also be acquired by a vertical 
transmission route (congenital transmission) because tachyzoites are able to across the 
placenta. In humans, transmission to the foetus occurs mostly when pregnant women get a 
primary infection during gestation (Montoya and Remington, 2008). 
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1.1.5. Genetics of T. gondii 
Strains of T. gondii are divided into three main clonal groups based on polymorphic 
markers and on virulence in laboratory mice. Remarkably, these clonotypes differ at the 
genetic level by only 1 to 2 % (Saeij et al., 2005; Su et al., 2003). Strains of the type I 
lineage are highly virulent in mice with a LD100 of less than 10 parasites whereas strains 
of the type II and III lineages are less virulent in mice with LD100 of more than 1000 
parasites (Kim and Weiss, 2004). Toxoplasma gondii has a nuclear genome consisting of 
14 linear chromosomes (around 65 Mb), a mitochondrial genome containing 6 kb tandem 
repeats and a 35 kb apicoplast genome (Figure 1.3) (Sibley and Ajioka, 2008). Genome 
sequences and annotations of strain ME49 (type II) of T. gondii as well as genomic 
sequence of strain GT1 (type I), VEG (type III) and chromosomes Ia and Ib of RH strain 
(type I) can be accessed via www.toxodb.org (Gajria et al., 2008).  
 
Figure 1.3. Genomes of Toxoplasma gondii.  
Nucleus, mitochondria, and apicoplast are organelles that contribute to the total genome of T. gondii (picture 
is adapted from Nishi et al., 2008; Sibley and Ajioka, 2008). The nuclear genome is composed of 14 linear 
chromosomes and around 65 Mb in size. The 6 kb tandem repeats of the mitochondrial genome encodes 
genes for cytochrome c oxidase subunits, cytochrome b and fragmented ribosomal RNAs and the 35 kb 
circular apicoplast genome encodes only a few genes encoding proteins including tandemly duplicated 
ribosomal RNAs and tRNAs (Sibley and Ajioka, 2008). 
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1.2. Programmed Cell Death (PCD)  
1.2.1. Classification of cell death 
Classification of cell death was initially made based on morphological 
characteristics. With progress in biochemical and genetic assays for the assignment of cell 
death-related phenomena, the Nomenclature Committee on Cell Death (NCCD) 
recommended  unified criteria for the definition of cell death which are based on different 
cell death morphologies  and biochemical features (Galluzzi et al., 2012; Kroemer et al., 
2009). This should facilitate the use of the same terminology by different scientists. 
According to the revised NCCD recommendations (Galluzzi et al., 2012), cell death can be 
functionally classified into extrinsic apoptosis, caspase-dependent or -independent intrinsic 
apoptosis, regulated necrosis, autophagic cell death and mitotic catastrophe.  
Definitions of each type of cell death according to the latest NCCD 
recommendation (Galluzzi et al., 2012) are as follows: 
1. Extrinsic apoptosis is defined as a caspase-dependent cell death which is induced 
by extracellular stress signal. The signal will then be recognised by specific 
transmembrane death receptors, such as Fas/CD95, TNFα receptor 1 and TRAIL 
receptor. This mechanism can be suppressed by pan-caspase chemical inhibitors 
(e.g. Z-VAD-FMK). The criteria of extrinsic apoptosis involve one of three major 
lethal signalling cascades. First, activation of the caspase 3 cascade following death 
receptor signalling and activation of caspase 8. Second, activation of caspase 3 that 
involves mitochondrial outer membrane permeabilisation (MOMP) which is 
initiated by translocation of tBID following death receptor signalling and activation 
of caspase 8. Or, third, caspase 3 that is activated following ligand deprivation-
induced dependence receptor signalling. 
2. Intrinsic apoptosis is a cell death mechanism in response to various intracellular 
stress signals such as DNA damage, oxidative stress, accumulation of unfolded 
proteins in the endoplasmic reticulum (ER stress), etc. This form of cell death is 
mediated by MOMP and is linked with generalised and irreversible mitochondrial 
membrane potential disruption, release of proteins from the intermembrane space of 
mitochondria (e.g. cytochrome c, Smac, Diablo, HtrA2, AIF, EndoG) into the 
cytosol, and inhibition of the mitochondria respiratory chain.  
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There are two subtypes of intrinsic apoptosis: caspase-dependent and caspase-
independent pathways based on a cytoprotective effect of caspase inhibition. 
3. Recently, necrosis is believed to at least partially occur in a regulated way, although 
for many years, it has been described as a cell death process that only occurs by 
accident (or uncontrolled). Necrosis lacks the features of apoptosis and autophagy. 
Regulated necrosis can be induced by alkylating DNA damage, excitotoxins and 
ligation of cell death receptors under certain circumstances.  
4. Autophagic cell death is a mechanism that is mediated by autophagy (cells eat 
themselves). The mechanism can be inhibited by chemicals and/or genetic means. 
Morphologically, autophagic cell death is characterised by a massive cytoplasmic 
vacuolisation.  
5. Mitotic catastrophe was occasionally used to define cell death occurring in mitosis. 
Lately, it has been proposed that mitotic catastrophe might not constitute a bona 
fide cell death executioner mechanism, but an oncosuppresive mechanism. The 
oncosuppresive process is initiated by disturbation of the mitotic machinery during 
the M phase of the cell cycle and coincides to some extent with a mitotic arrest, 
which finally induces cell death or senescence.  
 
Comparisons between types of cell death, morphologically and biochemically, are 












Chapter 1 Introduction 
 
Page | 9  
 
Table 1.1. Classification of cell death modalities 











Death receptor signalling 
Caspase 8 activation 
BID cleavage and 
MOMP 
Caspase 3 (6, 7) 
activation 
yes Pyknosis, chromatin 
condensation, plasma 
membrane blebbing 






Irreversible disruption of 
ΔΨm 
yes Pyknosis, chromatin 
condensation, plasma 
membrane blebbing 





Release of IMS proteins 
Inhibition of respiratory 
chain 
no Pyknosis, chromatin 
condensation, plasma 
membrane blebbing 
    
Autophagic 
cell death 
Lipidation of MAP1LC3  
Degradation of SQSTM1  
no Vacuolisation 
    
Necrosis Death receptor signalling 
Inhibition of caspase  
Activation of RIP1 
and/or RIP3  
no Nuclear membrane 
dilatation, circumscribed 
chromatin condensation, 
increased cell volume 
(oncosis) 
    
Mitotic 
catastrophe 
Caspase 2 activation (in 
some cases) 
TP53 or TP73 activation 
(in some cases) 
Mitotic arrest 





(modified from Galluzzi et al., 2012; Vitale et al., 2011). 
Abbreviations: ∆Ψm, mitochondrial membrane potential; IMS, intermembrane space; MAP1LC3, 
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1.2.2. Apoptosis in multicellular organisms 
Apoptosis is the most frequent phenotype of self-destruction of a cell. The term 
apoptosis has been originally introduced by Kerr et al. (1972) to define a type of cell death 
with specific morphological traits. The word ―apoptosis‖ in Greek means ―dropping off‖ or 
―falling off‖ of petals from flowers, or leaves from trees (Kerr et al., 1972 ). Apoptosis is 
an energy-dependent mechanism and a highly regulated process which plays crucial roles 
in the development of multicellular organisms as well as in the regulation and maintenance 
of the cell population under physiological and pathological circumstances (Elmore, 2007). 
Histologically, apoptosis is characterised by rounding-up of the cells, retraction of 
pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear 
fragmentation, plasma membrane blebbing and phagocytosis and degradation by other 
cells (Kerr et al., 1972; Kroemer et al., 2009). Biochemical features of apoptosis include 
protein cleavage, protein cross-linking, DNA fragmentation, and externalisation of 
phosphatidylserine to the outer leaflet of the plasma membrane (Elmore, 2007). 
Classical apoptosis pathway in vertebrates can be triggered by extrinsic (death 
receptor) or intrinsic (mitochondrial-dependent) stimuli (see section 1.2.1). The extrinsic 
pathway is activated by cell surface death receptors (TNF receptor, CD95/Fas, TRAIL 
death receptors, etc.) and the intrinsic pathway is associated with the formation of the so-
called apoptosome, which is formed by Apaf-1, cytochrome c and pro-caspase 9 (Jeong 
and Seol, 2008; Vaux and Strasser, 1996) (Figure 1.4). Both pathways can converge at the 
execution phase that is initiated by the cleavage of caspase 3 which then activates proteases 
and finally leads to degradation of nuclear material and cytoskeletal proteins (Elmore, 
2007).  
Inevitably, caspases are crucial molecules in apoptosis pathways in metazoans. 
There are several types of caspases, two of them are involved in mammalian apoptosis: 
initiator caspases (caspase 2, 8, 9 and 10) and executioner/effector caspases (caspase 3, 6, 
and 7). Caspases reside within cells in an inactive form and will be activated following 
triggering of apoptosis. Caspases have different substrate preferences but they always 
cleave their substrate after aspartate residues (Green, 2011; Shi, 2002).  
Although many studies have confirmed the critical importance of caspases in the 
regulation of apoptosis in metazoa, apoptosis can be executed by a mechanism which 
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ensues independently of caspases. Caspase-independent cell death is defined as a form of 
cell death that occurs when caspases cannot be activated following common stimuli of 
apoptosis.  Nevertheless this type of cell death often shares features as described during 
caspase-dependent apoptotic cell death (Tait and Green, 2008). 
 
Figure 1.4. Apoptosis pathways in mammalian cells.  
The extrinsic apoptosis pathway is initiated by transmembrane death receptor-mediated interactions. This 
interaction will activate caspase 8 which in turn activates a downstream caspase cascade and leads to cell 
death. On the other hand, caspase 8 cleaves Bid (BH3-only protein, pro-apoptotic member of Bcl-2 family) 
and the truncated Bid (tBid) translocates to mitochondria which results in the activation of intrinsic apoptosis 
pathway. Activation of the intrinsic (mitochondria-dependent) pathway leads to the release of cytochrome c 
into the cytosol, the formation of the apoptosome and activation of the caspase cascade. Members of Bcl-2 
family proteins play important roles in regulation of cytochrome c release. Bax and Bak (pro-apoptotic 
members of Bcl-2 family) translocate from the cytosol to mitochondrial membrane as homodimers. Anti-
apoptotic members of Bcl-2 family, Bcl-2 and Bcl-xL, inhibit the function of Bax and Bak. Release of Ca
2+
 
from the ER through the IP3R (inositol 1,4,5-triphosphate receptor) stimulates translocation of the DRP-1 
protein to mitochondria. Accumulation of Ca
2+ 
in mitochondria in turn is responsible for the release of 
cytochrome c, consequently leading to cell death. AIF and EndoG, proteins with nuclease activity, are 
released from mitochondria and translocated into nucleus.  They execute cell death independently of 
caspases. Mitochondria also release Smac/Diablo and Omi/HtrA2 and they block the activation of inhibitors 
of apoptosis (IAPs) (adopted from Jeong and Seol, 2008). Bax inhibitor-1, a protein that mainly localises at 
the ER membrane, acts as an anti-apoptotic regulator by interaction with Bcl-2 or Bcl-xL or by decreasing 
cytosolic Ca
2+
 level (Robinson et al., 2011; Xu and Reed, 1998). 
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Many proteins (caspases, cathepsins, endonucleases, calpains, and other proteases) 
play roles in the execution of apoptosis, and they can be regulated by several cellular 
organelles, including mitochondria and endoplasmic reticulum (ER) (Figure 1.4). These 
organelles and their specific apoptosis-related proteins may act independently or influence 
each other (Broker et al., 2005). 
In vertebrates, mitochondria are the central players in both caspase-dependent and 
caspase-independent apoptosis pathways. In caspase-dependent apoptosis pathway, 
mitochondria play pivotal roles by releasing molecules that induce caspase activation and 
chromatin condensation (Jeong and Seol, 2008). On the other hand, apoptosis-inducing 
factor (AIF) and Endonuclease G are released by mitochondria and act in a caspase-
independent fashion to execute apoptosis (Broker et al., 2005; Elmore, 2007; van Loo et 
al., 2001). The endoplasmic reticulum is also an important organelle in the execution of 
apoptosis pathways. It regulates apoptosis either by releasing cell death signals of its own 
as a response to ER stress or by transmitting death-promoting signals to mitochondria 
following death stimuli (Breckenridge et al., 2003; Hetz, 2007; Madeo and Kroemer, 





released from the ER will be taken up by mitochondria, causing 
mitochondrial damage and thus leading to cell death (Jaattela and Tschopp, 2003; Scorrano 
et al., 2003). 
 
1.2.3. Apoptosis-like cell death in unicellular organisms 
 Cell death, e.g. apoptosis, was until recently believed to be confined to multicellular 
taxa only. Nevertheless, there is increasing evidence that an ancestral form of apoptosis 
exists in unicellular organisms as well including protozoan parasites e.g. Leishmania spp, 
Plasmodium spp, Trichomonas vaginalis, Trypanosoma cruzi, Trypanosoma brucei, and 
Giardia lamblia (Bruchhaus et al., 2007; Jiménez-Ruiz et al., 2010; Reece et al., 2011). 
Apoptosis-like cell death in protozoan parasites shares characteristic features of apoptosis 
in metazoa, e.g. phosphatidylserine exposure, DNA fragmentation, chromatin 
condensation, loss of mitochondrial membrane potential, cell shrinkage, and protease 
activation (Bruchhaus et al., 2007; Jiménez-Ruiz et al., 2010) . However, the underlying 
molecular mechanisms of cell death in protozoan parasites obviously differ from those in 
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metazoans. For instance, bona fide caspases, i.e. key players of apoptosis in metazoans, are 
absent in protozoan parasites as are members of the Bcl-2 family (Nedelcu, 2009). Instead, 
other proteins or molecules may contribute to apoptosis-like cell death in protozoan, such 
as metacaspases, cathepsins, or calpain (Arnoult et al., 2002; Ch'ng et al., 2010; El-Fadili 
et al., 2010; Hurd et al., 2006). Considering that protozoan parasites do not express 
genuine caspases, it seems that apoptosis-like cell death in the parasites proceeds via a 
caspase-independent pathway.  
The existence of an apoptosis-like cell death in single-celled organisms has opened 
up an intriguing question: what is the benefit of a self-killing mechanism for protozoan 
parasites? There is now evidence for different functions of programmed cell death 
pathways in protozoan parasites. PCD could be useful to control cell proliferation, 
differentiation and survival of Trypanosoma cruzi (Ameisen et al., 1995), for limiting 
intensity of infection in the host as shown for the malaria parasite, Plasmodium berghei 
(Al-Olayan et al., 2002), or to evade host immunity in order to establish infection as 
described for Leishmania (van Zandbergen et al., 2006). PCD arguably plays essential 
roles in regulating parasites densities in distinct host compartments and in avoiding 
inflammatory responses to ensure a sustained infection (van Zandbergen et al., 2010). 
 Studies on elucidating programmed cell death in protozoan parasites are still scarce. 
Even though apoptosis-like cell death in unicellular organisms resembles apoptosis in 
metazoans as described above, the mechanisms still remain largely unclear. Studies on T. 
gondii programmed cell death are hitherto limited and consequently, there is only little 
information available regarding apoptosis or programmed cell death in T. gondii.  
When we consider T. gondii as a population of genetically identical organisms 
within its host (and T. gondii tissue cysts as a community of highly inter-dependent 
organisms possibly communicating between each other), a form of programmed cell death 
of a subpopulation may be evolutionary favorable and may increase the parasite fitness 
because it may avoid an overwhelming parasite load and host death. Furthermore, a 
mechanism known as apoptotic mimicry has been reported in T. gondii in order to dampen 
the host immune response by inducing TGF-ß secretion (Seabra et al., 2004). Finally, it has 
also been described that the parasite inhibits NO production by translocating 
phosphatidylserine (PS) to its outer leaflet of the plasma membrane in order to ensure its 
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persistence in activated macrophages (Seabra et al., 2004). Exposure of PS by T. gondii 
appeared to be also required to maintain parasite and host survival (Santos et al., 2011). 
Some markers of apoptosis, e.g. chromatin condensation, DNA degradation and hypoploid 
nuclei, have been described in the tachyzoite stage of T. gondii following treatment with 
the exogenous nitric oxide (NO) donor sodium nitroprusside (Peng et al., 2003).  
 
1.3. Objectives of the study 
Toxoplasma gondii is one of the most successful parasites that can infect humans 
and animals, leading to a major health problem worldwide. During recent years, 
programmed cell death (PCD), a common feature of multicellular organisms that is crucial 
to the development, homeostasis and integrity of multicellular organisms, has been 
described in unicellular organisms including protozoan parasites.  Limited information is 
available regarding programmed cell death in T. gondii. However, knowledge of how this 
parasite dies and whether this proceeds via distinct cellular pathways is a major of interest. 
Therefore, the focus of this study was to unravel cell death modalities in T. gondii and to 
characterise underlying mechanisms. Specifically, the aims of this study were to: 
1. characterise cell death phenotypes in T. gondii, 
2. determine the physiologic relevance of apoptosis-like cell death in T. gondii,  
3. identify molecules that may be involved in the regulation of apoptosis-like cell death 
in T. gondii, 
4. examine how cell death in T. gondii is regulated.  
 
Since apoptosis is the most common phenotype of cell death, this study focused on the 
identification of markers of apoptosis in T. gondii. We further determined when the 
parasite employs such form of cell death during its natural life cycle including tachyzoites 
and bradyzoites that contribute to acute and chronic infection, respectively. In addition, we 
determined whether the parasite undergoes apoptosis following treatment with pro-
apoptotic stimuli or drug treatment in vitro. We performed in silico analysis of the T. 
gondii genomic database and identified proteins that may play roles in apoptosis 
mechanism in T. gondii. Since caspases or members of the Bcl-2 family have not been 
identified in the genome of protozoan parasites, programmed cell death, if present, would 
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proceed independently of caspases. Endonuclease G and Bax inhibitors are of our interest 
in this study as both proteins have been reported to play a role in caspase-independent 
apoptosis pathway. Endonuclease G is a mitochondria-located endonuclease that is 
translocated to the nucleus where it cleaves chromatin DNA into nucleosomal fragments. 
Bax inhibitors are at least partially ER membrane-resident proteins that act as negative 
regulators of cell death caused by ER stress. Up to now, there are no reports on either T. 
gondii Bax inhibitors or EndoG. Considering the role of these proteins in apoptosis 
pathways, structure and function of these proteins in the metabolism of T. gondii and 
particularly in the regulation of apoptosis-like cell death in the parasite needs to be 
elucidated. We, therefore, in this study tried to identify the presence of genes encoding 
putative Bax inhibitors and EndoG via analysis from the Toxoplasma genomic database. 
We further intended to analyse their structure and designed approaches to analyse their 
function. Moreover, the involvement of mitochondria and proteases during PCD in T. 
gondii was analysed by detecting the mitochondrial membrane potential as well as caspase-
like activity in parasites that have been treated with pro-apoptotic stimuli. 
Currently available drug regimens against T. gondii are only effective against the 
tachyzoite stage but not the bradyzoite stage. Furthermore, those drugs are poorly tolerated 
and have severe side effects (Blader and Saeij, 2009). Therefore, the development of new 
approaches to treat the disease is a challenge to be solved. A better understanding of 
programmed cell death in T. gondii is required. Once the knowledge of molecular 
mechanisms of PCD in Toxoplasma is known, it would possibly open new possibilities to 
combat the parasite without strong stimulation of the host immune response. 
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CHAPTER 2  
MATERIALS AND METHODS 
 
2.1. Materials 
Disposable materials and plastic ware used in this study were purchased from Nunc, 
Falcon, Corning Costar or Braun.  
 
2.1.1. Cell lines, T. gondii and bacteria strains 
All cell lines, Toxoplasma gondii and bacteria, unless otherwise stated, were obtained from 
stocks available at the Institute for Medical Microbiology, Georg-August University 
Göttingen. 
HFF     Human foreskin fibroblasts 
HeLa229    Human cervical cancer cell line (European Collection  
     of Animal Cell Cultures/ECACC) 
L929     Mouse-derived fibroblasts 
ME49 (tissue cysts) T. gondii type II strain (kindly provided by Dirk 
Schlüter, Magdeburg) 
NTE     T. gondii type II strain (clinical isolate; Groß, 1991) 
E. coli DH5α 
E. coli BL21 (DE)3 
E. coli BL21 (DE)3 codon plus 
 
2.1.2. Cell death inducers 
All cell death inducers were purchased from Sigma-Aldrich. 
Table 2.1. Cell death inducers and concentrations used in this study 
Chemical  Stock solution Working concentration 
Brefeldin A  10 mM in DMSO 10 µM 
Camptothecin  50 mg/ml in DMSO 1 µM and 5 µM 
H2O2 200 mM in ddH2O 0.5 mM, 2 mM and 5 mM 
Miltefosine 500 mM in PBS 20 µM and 100 µM 
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2.1.3. Antibiotics and parasiticidal agents 
Drugs used in this study, unless otherwise stated, were purchased from Sigma-Aldrich. 
Table 2.2. Antibiotics and antiparasite drugs and concentrations used in this study 
Chemical  Stock solution Working concentration 
Ampicillin  100 mg/ml in ddH2O 100 µg/ml 
Anhydrotetracycline 2 mg/ml in DMF 25 ng/ml 
Anisomycin 10 mM in 70 % ethanol 100 nM and 500 nM 
Atovaquone  5 mM in DMSO 100 nM and 1 µM 
Chlorampenicol  34 mg/ml in ethanol 34 µg/ml 
Clindamycin hydrochloride 10 mM in 70 % ethanol 100 nM and 500 nM 
G418 (Biochrom AG) 100 mg/ml in ddH2O 700 µg/ml 
Penicillin/Streptomycin  
ready to use (Biochrom 
AG) 
10,000 U/ml/10,000µg/ml 1 % (v/v) 
Pyrimethamine 10 mM in 70 % ethanol 1 µM and 5 µM 
 
2.1.4.  Protease substrate and protease inhibitors 
Table 2.3.  Protease substrate and protease inhibitors and concentrations used in this study 
 
Staurosporine   1 mM in DMSO 0.3 µM, 5 µM, and 10 µM 
Thapsigargin   2 mM in DMSO 2 µM  
Tunicamycin 10 mM in DMSO 5 µg/ml 
Chemical  Stock solution Working concentration 
DEVD-AMC (Bachem) 10 mM in ddH2O 10 µM 
E64 (Sigma-Aldrich) 20 mg/ml in DMSO  100 µM 
Protease inhibitor cocktail 
(Roche) 
1 tablet dissolved in 400 µl 
ddH2O 
4 % (v/v) 
Z-VAD-FMK (Enzo Life 
Sciences/Alexis) 
10 mg/ml in DMSO 100 µM 
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2.1.5.  Antibodies 
Table 2.4. Antibodies used for Western blot (WB) or immunofluorescence assay (IFA) and 
concentrations used in this study 
Antibodies   Working dilution (WB; 
IFA)  
Anti-FLAG M2 (Stratagene) IFA 1:800 
Anti-His-tag Ab (Qiagen)  WB 1:1,000 
Anti-mouse-IgG HRP conjugate (Dianova) WB 1:2,000 
Cy2-conjugated anti-mouse IgG  (Dianova) IFA 1:400 
Cy3-conjugated donkey anti-rabbit IgG (Dianova) IFA 1:800 
Cy3-conjugated anti-rat antibody IgG (Dianova) IFA 1:400 
DC11 (rat anti-bradyzoites antibody; Institute for Medical 
Microbiology, Georg-August University Göttingen) 
IFA 1:100 
QIAexpress Strep-tag Ab (Qiagen)  WB 1:2,000 
RS7.2 (rabbit anti-T. gondii polyclonal antibody; Institute 




2.1.6.  Fluorescent probes 
In this study, Hoechst 33258 and propidium iodide (both were from Sigma-Aldrich) were 
used to stain nucleic acids. To label mitochondria with an intact mitochondrial membrane 
potential, MitoTracker
®
 Orange CM-H2TMRos (Invitrogen) was applied. 
 
2.1.7.  Oligonucleotides 
Primer sequences used in this study were designed using Primer3 software and were 
purchased from Sigma-Aldrich. 
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Table 2.5. Primer pairs for amplifying cell death-related genes via quantitative real time 
PCR 
Gene ID Forward (5‘ – 3‘) Reverse (5‘ – 3‘) Amplicon 
(bp) 
TgME49_008710 AGGCAGCGAAACACAGAAAG ACATGCAGGGAAGCTCCA 264 
TgME49_007620 CGCGTACCCATACGTGAAGA GCGACGAACTGTTGCTTGTC 234 
TgME49_078970 ACTTCGTCGCGTTTCACTTT ATGCAGTACGCATTGAGCAG 248 
TgME49_053000 AAGGCGAGAGGAATGGATTT CGTCGTAAAATTGCAGCAGA 201 
TgME49_094420 AGAGAGGAGGGAGACGAAGG CAGCGAACTGTGTTCGTCAT 156 
TgME49_093820 GACGATTCACACATGGTTGC TTGATTTTCCTGGGAGAACG 228 
TgME49_093830 GACCTCTCGGCTGTAGCATC CGCACCGTCTGTCAGAGTTA 158 
TgME49_021360 CTTCGTCAGCGGGAATATGT GCCGATAGTGAGTTGGGTGT 241 
TgME49_049770 GCCATTGTTCCACGTCTTTT GAAGGGGAAGGAAGGAGATG 162 
TgME49_109560 CCAGGACAATTTGCACACAC CGTCCGCTCTTTTCTTTACG 232 
TgME49_ 003030 CCAGGCTGCTACTCCTTACG GAACCCGTTTCAATGTCGAT 171 
TgME49_105490 TCTTGCCAGCGTGAATACTG GCGCTGATAGTCACTCCACA 247 
TgME49_105870 GATGCATTCTGTGCGTGTCT GGGACTCACCTGGATTCTGA 159 
TgME49_035560 TCCCAGTCCACAGAGTTCCT AGAGACGGCAAAGGATCAGA 209 
TgME49_107780 GTTGCTGGGATAGCTTCTGC GCCTTGAGAGGACAGAGGTG 240 
TgME49_035880 CCGAGCGAAGTTTTTACGTC CACCGAAAATGTGAGACACG 170 
TgME49_006490 TTCGTCCACTACGCTTGTTG GGGAGAATCGTTTCGTCGTA 207 
TgME49_009030  
(actin) 
TGGCAACGAGCGATTCCGCTG GTTCCTTGGTCAGCCTCTCGCC 200 
 
Table 2.6. Primer pairs for cloning and sequencing of T. gondii Endonuclease G 
Primers Sequence (5‘ – 3‘) 
TgEG_KlonipQE30_2_for NNNNNNGCATGCACTACTCCTTTCGTTTCTCCTCCTTC  
(SpHI site in bold letters) 
TgEG_KlonipQE30_2_rev NNNNNNAAGCTTTCAGTCGCCCAGAACAGAAGCG  
(HindIII site in bold letters) 
TgEG_KlonipASKIBA3_2_for NNNNNNGAATTCACTACTCCTTTCGTTTCTCCTCCTTC
TGC (EcoRI site in bold letters) 
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TgEG_KlonipASKIBA3_2_rev NNNNNNGGTACCGTCGCCCAGAACAGAAGCGATG 










2.1.8.  Plasmids 
TgEndoG-pBluescriptSK- Recombinant plasmid containing TgEndoG full length 
sequence (purchased from ATG:biosynthetics GmBH). 
pASK-IBA3 plus Expression plasmid. It contains an anhydrotetracycline 
(ATc)-regulatable promoter for generating C-terminal 
Strep-tagged proteins (IBA GmbH). 
pQE30  For recombinant protein expression in E. coli – generating 
proteins fused with a 6xHis-tag at the N-terminus 
(Stratagene). 
pRSET-A For recombinant protein expression in E. coli – generating 
proteins fused with a 6xHis-tag at the N-terminus (kindly 
provided by Antonio Jiménez-Ruiz, Madrid). 
 
2.1.9.  Molecular weight markers 
GeneRuler 100 bp DNA Ladder    Fermentas 
GeneRuler 1 kb DNA Ladder    Fermentas 
Prestained Protein Marker, Broad Range 
(6-175 kDa)      New England Biolabs 
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2.1.10.  Enzymes 
Alkaline antarctic phosphatase    New England Biolabs 
DNase I Amplification Grade   Sigma-Aldrich    
KOD DNA polymerase     Novagen 
Omniscript reverse transcriptase   Qiagen 
Quick T4 DNA Ligase     New England Biolabs 
Restriction Enzymes      New England Biolabs 
RNase A      Sigma-Aldrich 
Taq DNA polymerase     Roche 
 
2.1.11.  Kits 
Annexin V-PE apoptosis detection       BD Biosciences 
BCA
TM
 Protein Assay        Pierce 
CaspaTag
TM
 Pan-Caspase In Situ Assay Kit, Fluorescein  Chemicon International 
ECL detection reagent       Amersham    
FuGene HD Transfection Reagent      Roche   
GenElute
TM
 Mammalian Total RNA Miniprep     Sigma-Aldrich 
GenElute Plasmid Mini Prep Kit      Sigma-Aldrich   
GenElute Plasmid Maxi Prep Kit      Sigma-Aldrich 
In Situ Cell Death Detection, Fluorescein    Roche  
LightCycler
®
 FastStart DNA Master
PLUS 
SYBR Green I   Roche  
Omniscript
®
 Reverse Transcription      Qiagen 
QIAquick PCR Purification Kit      Qiagen  
Quick Ligation Kit        New England Biolabs 
 
2.1.12.  Other chemicals and reagents 
Acrylamide/bisacrylamide   Roth 
Agarose NEEO Ultra-Qualität  Roth 
Ammonium peroxodisulfate (APS)  Sigma-Aldrich 
Ampuwa sterile water    Sartorius 
BSA       Sigma-Aldrich 
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CHAPS     Sigma-Aldrich 
Diethanolamine    Fluka BioChemika      
Dimethylformamid    Fluka BioChemika 
EDTA      Merck 
Mowiol     Calbiochem      
PBS      Biochrom AG 
Ponceau S     Roth 
Roti
®
-Blue      Roth 
Saponin      Sigma-Aldrich 
Sodium azide      Merck   
Sodium citrate     Biochrom AG    
TEMED      Roth     
Triton X-100      Sigma-Aldrich 
Trypsin      Biochrom AG 
Tween 20      Biochrom AG 
 
2.1.13. Instruments 
Centrifuges      Megafuge 2.0 (Heraeus) 
Megafuge 2.0 RS (Heraeus) 
Multifuge 3 S-R (Heraeus) 
Avanti
 
J-25 (Beckman Coulter) 
5417 R (Eppendorf) 
5424 (Eppendorf) 
5403 (Eppendorf) 
Digital balances     LP6200 S (Sartorius) 
CP 224 S (Sartorius) 
Electrophoresis power supply   EPS 500/400 (Pharmacia Fine Chemicals) 
FACS       FACSCalibur (BD Biosciences) 
Gel documentation system    BioDoc II
 
(Biometra) 
Gel electrophoresis     Mini Protean II (BioRad) 
Incubators      Type BB 6220 CU (Heraeus) 
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Laser scanning confocal microscope  TCS SP 2 (Leica) 
Light cycler     LightCycler
®
 Carousel-Based System (Roche)  
Light microscopy     Model DM IL (Leica) 
      Axiostar plus (Zeiss) 
Luminescent image analyzer   Image Reader LAS-4000 (Fujifilm) 
Luminometry      Victor V multilabels counter (Perkin Elmer) 
Magnetic stirrer    RCT basic (IKA Labortechnik) 
pH Meter      Calimatic 766 (Knick) 
Photometer      Ultraspec 1000 (Pharmacia Biotech) 
Pipette aids      Pipetboy acu (IBS Integra Biosciences) 
Pipetus-akku (Hirschman Laborgerate) 
Pipettes      Eppendorf 
Semi-dry gel transfer      Semi-dry electroblotter (Sartorius) 
Sonicator     Sonifier 250 (Branson) 
Shaker      Polymax 1040 (Heidolph) 
      Duomax 1030 (Heidolph) 
Thermocycler     Model T3 (Biometra) 





2.2.1. Maintenance of cells and cell harvest 
2.2.1.1.  In vitro cultivation of Toxoplasma gondii 
Toxoplasma gondii strain NTE was used for all experiments involving T. gondii 
tachyzoites. Tachyzoites were propagated in L929 cells in 12-well plates at 37
o
C, in a 5 % 
CO2 humidified atmosphere in Toxoplasma medium (see below). Extracellular parasites 
released from lysed host cells (approximately 3-4 days post inoculation/p.i) were used for 
re-inoculation at different parasite-host cell ratios, ranging from 6 to 2 drops of parasites 
and 5 to 3 drops of L929 in 1.5 ml Toxoplasma medium. 
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Toxoplasma medium 
RPMI 1640      
1 % (v/v) heat-inactivated FCS 
100 U/ml Penicillin/100µg/ml Streptomycin 
 
2.2.1.2. Production of brain cysts 
The avirulent type II ME49 cysts-forming strain of T. gondii was a kind gift from Dirk 
Schlüter, Magdeburg.  Brains from chronically infected mice were isolated at 10 to 30 
weeks p.i, homogenised using glass beads and spread onto glass slides for further 
experiments. To infect mice for brain cyst development, 5-10 cysts were intraperitoneally 
inoculated into NMRI mice. 
 
2.2.1.3. Cultivation of wild type and transfected cell lines 
All cell lines were grown at 37
o
C, 5 % CO2 in a humidified atmosphere. Human Foreskin 
Fibroblast (HFF), HeLa cells and Toxoplasma gondii Bax inhibitors (TgBIs)-expressing 
HeLa cells were grown in 75cm
2
 flasks with DMEM medium supplemented as indicated 
below. The cells were detached by rinsing with 3-5 ml 1 % (w/v) EDTA (Biochrom AG) 
and subsequent incubation in 3-5 ml 0.25 % (w/v) trypsin (Biochrom AG). After 
resuspension in cell culture medium, the cells were then centrifuged at 400 x g for 5 min 
and used for subcultivation. Subcultivation of L929 was done by scraping the cells using a 
cell scraper, and 6 to 8 drops of cell suspension were transferred into a 6-well plate with 4 
ml L929 medium. Subcultivation was done twice a week. 
 
L929 medium HeLa/HFF medium 
DMEM  DMEM  
1 % (v/v) heat-inactivated FCS 10 % (v/v) heat-inactivated FCS 
100 U/ml Penicillin/ 
100 µg/ml Streptomycin 
100 U/ml Penicillin/ 
100 µg/ml Streptomycin 
1 x non-essential amino acid 1 x non-essential amino acid  
1 mM sodium pyruvate  1 mM sodium pyruvate 
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2.2.1.4. Harvesting of T. gondii tachyzoites 
Extracellular tachyzoites were harvested by differential centrifugation at 35 x g for 5 min 
to separate them from host cells. The supernatant, which contained the parasites, was then 
transferred into a fresh tube and centrifuged at 1,314 x g for 10 min. Pelleted parasites 
were resuspended in 10 ml Toxoplasma medium and centrifuged again at 1,314 x g for 10 
min. The pellet was then resuspended in 1 ml medium and parasites were counted in a 
hemocytometer grid (see below). 
 
2.2.1.5.  Harvesting mammalian cells 
HFF, HeLa, or TgBIs-transfected HeLa cells were detached using EDTA and trypsin as 
described above (section 2.2.1.3). After centrifugation, cells were washed once by 
resuspension in cell culture medium and centrifugation at 400 x g for 5 min. Pelleted cells 
were resuspended in HeLa/HFF medium. An appropriate dilution of the cells was then 
mixed with an equal volume of 0.1 % (w/v) tryphan blue in PBS in order to determine the 
number of viable cells using a hemocytometer grid. 
 
2.2.1.6.  Cell count 
A hemocytometer (Improved Neubauer) was used to determine the amount of cells by 
using the formula:  




2.2.1.7.  Cryopreservation of cells 
After counting the cells, 1 x 10
7
 cells per ml were mixed gently with an equal volume of 
freezing medium (see below) and transferred in a cryotube. The cells were stored 
immediately at -80
o
C overnight before transferring them into liquid nitrogen for long-term 
storage. To recultivate frozen cells, they were thawed in a 37
o
C waterbath and were 
immediately transferred into a 50-ml centrifuge tube with the appropriate cell culture 
medium. After centrifugation at 400 x g for 5 min (mammalian cells) or 1,314 x g for 10 
min (T. gondii), pelleted cells were resuspended in cell culture medium, transferred into a 
flask or co-cultivated with host cells, and incubated at 37
o
C in a 5 % CO2 humidified 
atmosphere. 
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Freezing medium 
40 % cell culture medium  
40 % (v/v) FCS 
20 % (v/v) DMSO 
 
2.2.2. Determination of apoptosis markers  
2.2.2.1. DNA strand breaks and cell size reduction in extracellular parasites 
Terminal deoxynucleotidyl transferase-mediated X-dUTP nick end labelling (TUNEL) 
assay followed by flow cytometry was employed to determine DNA strand breaks and 
reduction of cell volume, which are hallmarks of apoptosis. For this purpose, tachyzoites 
were seeded at a cell density of 2 x 10
7
 parasites in 500 µl Toxoplasma medium in a 24-
well plate for 72 h. The parasites were treated with 5 µM and 10 µM staurosporine, 20 µM 
and 100 µM miltefosine, 0.5 mM and 2 mM H2O2, 1 µM and 5 µM camptothecin, or were 
left untreated. They were harvested at 0 (freshly isolated parasites), 6, 24, 48, and 72 h post 
treatment. All samples were centrifuged at 1,800 x g for 10 min, washed with PBS and 
fixed in 4 % (w/v) paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at room 
temperature. TUNEL staining was performed using the In Situ Cell Death Detection, 
Fluorescein kit (Roche) as recommended in the manufacturer‘s instruction. Briefly, after 
washing with PBS, the fixed cells were irreversibly permeabilised with 0.1 % Triton X-100 
in 0.1 % sodium citrate for 5 min at room temperature. The cells were then centrifuged at 
1,800 x g for 10 min. Pelleted cells were resuspended in 30 µl TUNEL solution (1:10 of 
enzyme in labelling solution), and incubated for 1 h at 37
o
C in the dark. The cells were 
then washed once with PBS. Finally, cells were resuspended in 500 µl PBS and measured 
by flow cytometry using a FACSCalibur (BD Bioscience) and analysed by Cellquest Pro 
as software. A total of 50,000 events were collected from each sample. TUNEL-positive 
cells were determined from the logarithmic FL-1 Height histogram. An alteration in cell 
size was measured in parallel by comparing the mean of forward scatter (FSC) value from 
different samples. 
To evaluate the TUNEL reactivity of T. gondii microscopically, a 50 µl aliquot of parasite 
suspension treated or not with pro-apoptotic stimuli was spread onto glass slides, air-dried, 
and fixed in 4 % (w/v) paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at 
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room temperature. The samples were blocked/permeabilised in 0.1 mg/ml saponin and 1 % 
BSA in PBS (blocking solution) for 1 h at room temperature. After having been washed 
with 0.1 mg/ml saponin in PBS (washing solution) for 10 min, the cells were incubated 
with rabbit anti-T. gondii polyclonal antibody RS7.2 (diluted 1:1,000 in blocking solution) 
for 1 h at room temperature. After three washing steps (10 min for each step) with washing 
solution, the cells were incubated with Cy3-conjugated donkey anti-rabbit IgG (diluted 
1:800 in blocking solution). Following three washing steps, the cells were irreversibly 
permeabilised with 0.1 % Triton X-100 in 0.1% sodium citrate for at least 5 min at room 
temperature. The parasites were then incubated in 60 µl TUNEL mixture to ensure proper 
distribution of the solution on the parasites. Afterwards, the cells were washed twice with 
PBS and mounted using Mowiol 4-88 (Calbiochem). The number of TUNEL-positive cells 
was counted from at least 350 parasites using confocal laser scanning microscopy with a 
63x oil-immersion objective. In some experiments, nuclei were counterstained with 
Hoechst 33258. To this end, after TUNEL staining, the parasites were washed twice in 
PBS and were then incubated in 2 µg/ml Hoechst 33258 (stock 1 mg/ml, diluted in 0.1 
mg/ml saponin in PBS) for 45 min at room temperature in the dark. Afterwards, cells were 
washed three times with PBS, rinsed shortly in ddH2O and mounted using Mowiol 4-88. 
The nuclei stained with TUNEL and Hoechst 33258 were documented using a 
conventional fluorescence microscopy (Zeiss). 
 
2.2.2.2. DNA strand breaks in intracellular parasites 
To examine the presence of TUNEL-positive intracellular parasites upon cell death 
induction, confluent HFF cells grown on glass cover slips in a 24-well cell culture plate 
were inoculated with 10
5
 tachyzoites per well. After 24 h of infection, 10 µM staurosporine 
or 20 µM miltefosine was added. T. gondii-infected non-treated HFF cells were used as 
controls. The cells were fixed after 3, 6, and 24 h post treatment with 4 % 
paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at room temperature. 
Samples were simultaneously blocked/permeabilised in 0.1 mg/ml saponin and 1 % BSA 
in PBS for 1 h at room temperature. The parasites were then labelled with parasite-specific 
antibody and TUNEL as described above (section 2.2.2.1). Cells were examined by 
confocal laser scanning microscopy. 
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2.2.2.3. Detection of phosphatidylserine exposure 
An Annexin V-Phycoerythrin (PE) apoptosis detection kit was used to quantify the 
translocation of phosphatidylserine from the inner to the outer leaflet of the plasma 
membrane after treatment of parasites with pro-apoptotic stimuli. To this end, 2 x 10
7
 
parasites were incubated in the presence of 10 µM staurosporine or 20 µM miltefosine for 
24 and 48 h. As controls, non-treated parasites were used. Samples were washed twice 
with ice-cold PBS and then resuspended in 1 x Annexin V-binding buffer (provided in the 
kit) at a concentration of 1 x 10
6 
cells per ml. A 100 µl aliquot of parasite suspension (1 x 
10
5 
cells) was then mixed with 5 µl of Annexin V-solution and 5 µl of 7-AAD-solution, 
and was incubated for 15 min at room temperature in the dark. After adding 400 µl of 1 x 
Annexin V-binding buffer to each sample, cells were analysed by flow cytometry. Non-
stained cells, cells stained with Annexin V alone, and cells stained with 7-AAD alone were 
used as controls to set up compensation parameters and quadrants. Data from 10,000 
events per sample was collected using a BD FACSCalibur flow cytometer and analysed 
using Cellquest Pro as software. 
 
2.2.2.4. Effect of pro-apoptotic stimuli on parasite invasiveness 
To evaluate the ability of extracellular parasites that have been treated with pro-apoptotic 
stimuli to invade host cells,  2 x 10
7
 parasites were pre-treated with 10 µM staurosporine or 
20 µM miltefosine or were left untreated for 48 h. At the indicated time point, parasites 
were isolated and washed once with HFF cell culture medium by centrifugation at 1,800 x 
g for 10 min. Confluent HFF cells which have been seeded on glass cover slips within the 
wells of a 24-well plate were then inoculated with 2x10
5
 parasites per well in the absence 
of pro-apoptotic stimuli. After 4 h, the medium was exchanged to remove extracellular 
parasites and cells were incubated for further 48 h. Cells were then fixed in 4 % (w/v) 
paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at room temperature and 
parasites were stained with parasite-specific antibody as described above (section 2.2.2.1, 
without TUNEL staining). The number of parasites which had invaded host cells was 
counted in 10 randomly selected visual fields per sample. Results were presented as the 
number of parasitophorous vacuoles per visual field. 
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2.2.3. Physiological significance of apoptosis-like cell death in T. gondii 
2.2.3.1. TUNEL staining of T. gondii from the peritoneal cavity during acute 
toxoplasmosis in mice 
NMRI mice were inoculated with 50, 100 or 500 T. gondii  NTE tachyzoites i.p. At 7, 10 
and 12 days p.i, the mice were killed by CO2 inhalation and the intraperitoneal fluid was 
collected by first injecting 7-8 ml ice-cold PBS and then aspirating the diluted 
intraperitoneal exudate. After centrifugation at 35 x g for 5 min, the supernatant was 
transferred into a new tube and was centrifuged again at 1,314 x g for 10 min. Pelleted 
cells that contain parasites was resuspended in 1 ml 1 x PBS. An aliquot of 50 µl 
intraperitoneal fluid was then spread onto slides, air-dried, and fixed in 4 % (w/v) 
paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at room temperature. Finally, 
parasites were stained as described above (section 2.2.2.1). 
 
2.2.3.2. TUNEL staining of brain cysts from chronically infected mice 
Homogenised brain from chronically Toxoplasma-infected mice (see 2.2.1.2) was spread 
on glass slides, air-dried and fixed in ice-cold absolute methanol at room temperature for 5 
min. The cells were then blocked/permeabilised in 1 % BSA and 0.2 % Triton X-100 in 
PBS pH 7.4 (blocking solution) for 1 h. Thereafter, bradyzoites-containing tissue cysts 
were immunolabelled with DC11 rat anti-T. gondii bradyzoite antibody (diluted at 1:100 in 
blocking solution) for 1 h. After having been washed three times in PBS, cells were 
incubated in Cy3-conjugated anti-rat IgG antibody (diluted 1:400 in blocking solution) for 
1 h in the dark. Afterwards, cells were washed as above and were incubated in 0.1 % 
Triton X-100 in 0.1 % sodium citrate for 15 min and then TUNEL-stained as described in 
section 2.2.2.1. Samples were examined by confocal laser scanning microscopy.  
 
2.2.3.3. Apoptosis-like cell death after treatment of parasites with chemotherapeutic 
agents 
HFF cells were seeded in 24-well plates containing 13 mm round cover slips at a density of 
40,000 cells per well. After having reached confluence, the cells were infected with 10
5
 
tachyzoites per well. Four hours after infection, the monolayer cells were washed to 
remove extracellular parasites and cell culture medium was replaced by fresh medium 
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containing 100 nM and 500 nM anisomycin, 1 µM and 5 µM pyrimethamine, 100 nM and 
1 µM atovaquone or 100 nM and 500 nM clindamycin. Infected cells cultured without any 
drugs were used as controls. At 24 and 48 h post treatment, cells were fixed in 4 % (w/v) 
paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at room temperature. Due to 
the delayed anti-parasitic effect of clindamycin (Fichera et al., 1995; Pfefferkorn et al., 
1992), treatment with this drug was done during two consecutive cycles. Samples of the 
first cycle were simultaneously fixed with other treated samples. For the second cycle of 
treatment, parasites which egressed from the host cells during the first cycle of 
clindamycin treatment (3-4 days p.i) were isolated by centrifugation at 1,800 x g for 10 
min. Pelleted parasites were resuspended in HFF cell culture medium and fresh HFF cells 
were infected with 25 % of parasites from the first cycle in the presence of clindamycin. At 
24 and 48 h after the addition of drugs, staining of parasites and TUNEL test were 
performed as described above. Parasite replication was determined by counting the number 
of tachyzoites per parasitophorous vacuole (at least 100 parasitophorous vacuoles per 
sample were inspected). The presence of TUNEL-positive parasites was monitored and 
documented by confocal laser scanning microscopy with a 63x oil-immersion objective. 
 
2.2.4. Putative regulators of apoptosis-like cell death in T. gondii 
To identify putative cell death regulators of apoptosis-like cell death in T. gondii, in silico 
analysis of the Toxoplasma genomic database (www.toxodb.org) was performed. 
Seventeen genes associated with cell death have been identified using a text-centered 
approach from the Toxoplasma genomic database (Chapter 3, Table 3.1). 
 
2.2.4.1.  RNA isolation and cDNA synthesis 
Total RNA was extracted from 7 x 10
7
 parasites, which had been previously incubated 
with 10 µM staurosporine or 20 µM miltefosine for 24 and 48 h. RNAs from treated 
parasites, from freshly isolated parasites and non-treated controls were isolated according 
to the manufacturer‘s instruction (GenElute
TM
 Mammalian Total RNA Miniprep). 
Contaminating DNA was digested by incubation of 50 µl of isolated total RNA with 5 µl 
DNase I and 5 µl DNase buffer (provided in the DNase I Amplification Grade kit, Sigma-
Aldrich) for 15 min at room temperature.  The reaction was stopped by adding 5 µl stop 
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solution and DNase was inactivated by incubation for 10 min at 60
o
C. For the cDNA 
synthesis reaction, up to 2 µg DNase-treated RNA were mixed with 1 x RT buffer, 0.5 mM 
of each dNTP, 10 U RNase inhibitor, 1 µM oligodT primer and 4 U Omniscript
®
 Reverse 
Transcriptase and RNase-free water in a total volume of  20 µl. Synthesis of cDNA was 




2.2.4.2.  Primer design and quantitative real-time PCR  
The synthesized cDNA was subjected to quantitative real time PCR using the primer pairs 
as shown in Table 2.5 (see 2.1.7). All primer pairs were designed using Primer3 software 
and were purchased from Sigma-Aldrich. For 20 µl PCR reactions, the following 
components were mixed: 2 µl of cDNA, 0.25 µM each of forward and reverse primers, and 
4 µl of buffer and enzyme mixture (provided in the LightCycler
®
 FastStart DNA 
Master
PLUS
 SYBR Green I kit, Roche). The amplification was carried out in a LightCycler
®
 
Carousel-Based System (Roche) using a cycling program as follows: (i) denaturation at 
95
o
C for 10 min, 45 cycles of (ii) denaturation at 95
o
C for 10 sec, (iii) annealing at 62
o
C 
(with the exception of calpain: 65
o
C) for 5 sec, and (iv) extention at 72
o
C for 20 sec, (v) 




C, (vi) final incubation at 40
o
C until stopping 
the PCR. The up- or down-regulation of transcript levels between two samples was 
calculated on basis of the crossing point (CP) values from the samples which were 
normalized to actin using the formula:  





Target refers to putative cell death-associated genes. 
 
2.2.4.3. Heterologous expression of Toxoplasma gondii Bax inhibitors (TgBIs) 
2.2.4.3.1. Transfection of TgBIs-coding genes into HeLa cells 
In silico analysis of the Toxoplasma genomic database revealed the presence of three 
putative T. gondii Bax inhibitors (TgBI-1, TgBI-2, and TgBI-3). Genes encoding TgBIs 
(identified and cloned in the lab of Dominique Soldati-Favre, Geneva) had previously been 
subcloned into a FLAG tag-containing mammalian expression vector (pCMV-SC-NF) and 
recombinant plasmids were extracted using the GenElute Plasmid Maxi Prep Kit (Sigma-
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Aldrich). Subcloning TgBIs coding sequences into pCMV-SC-NF, propagation of the 
recombinant plasmids and extraction of the plasmids have been done by Julia Hofhuis, a 
master student who performed her lab rotation at the Institute for Medical Microbiology, 
Georg-August University of Göttingen. 
In order to analyse the function of TgBIs in a well-established system of apoptosis, genes 
encoding these proteins were heterologously expressed in HeLa cells. To this purpose, 
HeLa cells were seeded in a 12-well plate at a density of 150,000 cells per well for 24 h in 
complete HeLa medium (section 2.2.1.3). The medium was then replaced by DMEM 
containing 3 % FCS prior to the transfection procedure. Transfection was done using 
FuGene HD Transfection Reagent (Roche) according to the manufacturer‘s 
recommendation (ratio of transfection reagent to recombinant plasmid 4:2 and 6:2) for 15 
min at room temperature. The transfection solution was added to the cells in a drop-wise 
manner. The plates were swirled to ensure gentle mixing of the transfection solution and 
were then incubated for 4 h at 37
o
C before changing the medium to complete HeLa cell 
culture medium again. At 48 h following transfection, G418 (700 µg/ml) was added for 
selection of stable transfectants. After several days (~7 days), the medium was replaced 
with fresh medium containing G418.  After having reached confluence, transfectants were 
transferred into 6-well plates, and afterwards into 75cm
2
 flask. As controls, non-transfected 
HeLa cells were grown in complete medium without and with G418. Stable transfection of 
the genes encoding TgBIs into HeLa cells was confirmed by immunofluorescence 
microscopy (see below). 
To obtain single clones of each TgBI-transfected HeLa cell line, pools of stably transfected 
HeLa-TgBI-1, HeLa-TgBI-2 and HeLa-TgBI-3 were seeded at one cell per well in 96-well 
plates (in complete HeLa medium supplemented with G418). Cells from single clones per 
well were selected (approximately at 7 days after seeding) and were transferred into 6-well 
plates for further propagation. Cells from single clones were then evaluated for efficient 
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2.2.4.3.2.  Indirect immunofluorescence assay 
HeLa and TgBIs-transfected HeLa cells were seeded in a 24-well plate with 13 mm round 
glass cover slips at a density of 75,000 cells per well. After 24 and 48 h, cells were washed 
once in PBS, fixed in 4 % (w/v) paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 
1 h at room temperature and were then incubated for 10 min in 50 mM NH4Cl in PBS at 
room temperature. The cells were blocked/permeabilised with 0.1 mg/ml saponin and 1 % 
in PBS (blocking solution) for 1 h at room temperature. After having been washed with 0.1 
mg/ml saponin in PBS (washing solution), cells were incubated with anti-FLAG antibody 
(diluted 1:800 in blocking solution) for 1 h at room temperature. The cells were then 
washed three times (10 min for each step) with washing solution before being incubated 
with Cy2-conjugated anti-mouse IgG antibody (diluted 1:400 in blocking solution) for 1 h 
at room temperature in the dark. Following three washing steps and a subsequent washing 
step in PBS for 10 min, the cells were incubated in 5 µg/ml propidium iodide in PBS for 5 
min in order to visualize the whole cell population. The samples were then washed twice (5 
min each) in PBS, were shortly rinsed with ddH2O, and finally mounted with Mowiol 4-88. 
The cells were analysed by confocal laser scanning microscopy with a 63x oil-immersion 
objective.  
 
2.2.4.3.3.  Colocalisation of TgBIs 
MitoTracker
®
 Orange CM-H2TMRos was employed for detecting a possible co-
localisation of TgBIs with mitochondria in HeLa-TgBIs. To this end, 1.5 x 10
4
 HeLa or 
TgBIs-expressing HeLa cells per well were grown on 13 mm round glass cover slips in a 
24-well plate. When cells have reached confluence, HeLa cell culture medium was 
replaced with pre-warmed DMEM without supplement but containing 500 nM 
MitoTracker
®
 probe for 45 min at 37
o
C. After having been washed in DMEM for 5 min at 
37
o
C, cells were washed for 5 min with 1 x PBS at room temperature before fixing them 
with 4 % paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 15 min at room 
temperature. Cells were then permeabilised using 0.25 % Triton X-100 in PBS for 15 min 
and were thereafter blocked with 1 % BSA in PBS (blocking solution) for 1 h. Cells were 
further incubated with anti-FLAG antibody (diluted 1:800 in blocking solution) for 1 h at 
room temperature. Cells were then washed three times (10 min for each step) with 1 x PBS 
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before being incubated with Cy2-conjugated anti-mouse IgG antibody (diluted 1:400 in 
blocking solution) for 1 h at room temperature in the dark. Following three washing steps 
as above, cells were shortly rinsed with ddH2O and finally mounted with Mowiol 4-88. 
The cells were analysed by confocal laser scanning microscopy with a 63x oil-immersion 
objective.  
 
2.2.4.3.4. Measurement of caspase 3/7 activity  
HeLa and TgBIs-expressing HeLa cells were seeded in 92 mm cell culture dishes (1.5 x 
10
6
 cells per dish). On the following day, cells were treated with 0.3 µM staurosporine or 
10 µM brefeldin A or were left untreated, and incubated for 24 and 48 h. At the indicated 
time points, cells were then isolated by EDTA/trypsin treatment (see 2.2.1.3) and 
centrifuged at 400 x g for 5 min. After having been washed in PBS, cells were transferred 
into microcentrifuge tubes and centrifuged again at 3,400 x g (6,000 rpm) for 3 min at 4
o
C. 
Pelleted cells were lysed in 50 µl NP-40 buffer (see below) supplemented with 4 % 
protease inhibitor cocktail on ice for 15 min. The supernatants were collected by pelleting 
insoluble material at 18,400 x g (14,000 rpm) for 5 min at 4
o
C. They were stored at -80
o
C 
until use or directly subjected to a caspase activity assay.  
To this end, an equal amount of proteins from each sample was applied for the activity 
assay; protein concentrations were measured as described below (see section 2.2.4.4.5). 
After adjusting an equal protein concentration in all samples, 10 µl of supernatant was 
pipetted into the wells of a 96-well plate, and then mixed with 90 µl reaction buffer 
containing DEVD-AMC, i.e. the substrate of caspase 3 or 7. Each sample was prepared in 
triplicate and NP-40 buffer was used as a blank. Cleavage of the substrate was measured 
using a multi-label microplate reader at 37
o
C at excitation and emission wavelengths of 
380 and 460 nm, respectively. The fluorescence was recorded every 5 min during a period 
of 60 min. The caspase activity was assessed by calculating the increase in the 
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NP-40 lysis buffer pH 8.0 Reaction buffer 
150 mM NaCl 0.1 mg/ml BSA (in MDB buffer) 
50 mM Tris base 0.1 % CHAPS (in MDB buffer) 
1 % Nonidet P40 10 µM DEVD-AMC 
  
MDB buffer  
10 mM HEPES pH 7.0  
40 mM β-glycerophosphate  
50 mM NaCl  
2 mM MgCl2  
5 mM EGTA  
 
2.2.4.3.5. Quantification of protein concentration  
Protein concentrations were measured in a microplate format following the instructions 
from the BCA
TM
 Protein Assay Kit. In brief, 25 μl of each BSA standard (provided in the 
kit as stock solution with a concentration of 2 mg/ml) with known concentration, ranging 
from 125 to 1,500 µg/ml (stock solution of BSA was diluted in NP-40 lysis buffer), or 
unknown samples were transferred in duplicate into the wells of a 96-well plate. 
Thereafter, 200 μl of working reagent (prepared by mixing 50 parts of reagent A with 1 
part of reagent B) were added to each well and the plate was mixed thoroughly on a plate 
shaker for 30 sec. Samples were then incubated for 30 min at 37
o
C before measuring the 
optical density in a microplate reader at 550 nm. The protein concentrations of unknown 
samples were calculated using a standard curve equation. 
 
2.2.4.3.6.  Analysis of hypoploid DNA  
To quantitatively measure apoptotic nuclei, staining with propidium iodide and flow 
cytometry have been performed. For this purpose, HeLa and TgBIs-expressing HeLa cells 
were seeded in a 6-well plate (2.5 x 10
5 
cells per well) overnight. They were then treated 
with 0.3 µM staurosporine or 10 µM brefeldin A or were left untreated. Cells were 
harvested at 24 and 48 h post treatment by centrifugation at 400 x g for 5 min. Pelleted 
cells were resuspended in 300 µl PBS containing 5 % FCS, permeabilised by adding 750 
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µl ice-cold 70 % ethanol and incubated for 10 min at 4
o
C. After cells have been washed 
with PBS, 50 µg/ml propidium iodide in PBS and 0.5 mg/ml RNase A were added and the 
cells were incubated for additional 20 min at room temperature in the dark.  Stained cells 
were then centrifuged as above, washed in 500 µl PBS and finally resuspended in 500-750 
µl PBS. At least 10,000 cells of each sample were analysed by flow cytometry 
(FACSCalibur).  
 
2.2.4.3.7.  Redistribution of TgBIs during cell death induction in transgenic HeLa 
cells 
HeLa and TgBIs-expressing HeLa cells were seeded on 13 mm round glass cover slips in a 
24-well plate (75,000 cells per well). Cells were treated with 0.3 µM staurosporine, or 10 
µM brefeldin A, or were left untreated for 24 and 48 h. At the indicated time points, cells 
were washed once in PBS, fixed in 4 % (w/v) paraformaldehyde in 0.1 M sodium 
cacodylate pH 7.4 for 1 h at room temperature and were then blocked/permeabilised in 0.1 
mg/ml saponin and 1 % in PBS (blocking solution) for 1 h at room temperature. Staining 
of TgBIs using anti-FLAG primary antibody and Cy2-conjugated secondary antibody was 
carried out as described in section 2.2.4.3.2. 
 
2.2.4.4.  Putative T. gondii Endonuclease G (TgEndoG) 
2.2.4.4.1. Cloning procedure 
2.2.4.4.1.1.  Digestion of plasmid or PCR products 
The TgEndoG coding sequence (TgME49_008710) was released from pBluescript SK-
TgEndoG recombinant plasmid (synthetically generated, purchased from 
ATG:biosynthetics GmBH) by digestion with EcoRI and KpnI and was subcloned into 
EcoRI- and KpnI-digested pASK-IBA3 plus vector. Digestion was performed by 




Alternatively, TgEndoG coding sequence was amplified from the pASK-IBA3-TgEndoG 
recombinant vector using primer pairs (see Table 2.6) which introduced appropriate 
restriction enzyme sites; SpHI and HindIII for cloning into pQE30 or EcoRI and HindIII 
for cloning into pRSET-A. Amplification was carried out by incubating (final 
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concentration) 1 x buffer, 1.5 mM MgSO4, 0.2 mM of each dNTP, 0.3 µM of each forward 
and reverse primer, 5 % (v/v) DMSO, 1 µl plasmid, 0.02 U KOD DNA polymerase and 
ddH2O to give a final volume of 25 µl. The target sequence was amplified by PCR using 
the following cycling program: (i) denaturation at 95
o
C for 2 min, 40 cycles of (ii) 
denaturation at 95
o
C for 20 sec, (iii) annealing at 60
o
C for 10 sec, (iv) extention at 70
o
C for 
1 min, and (v) a final extention at 70
o
C for 5 min. PCR products were purified using the 
QIAquick PCR purification kit (Roche) as described in the manufacturer‘s protocol. Ten µl 
of purified PCR product was then double-digested by adding 1 µl of SpHI and HindIII, and 
buffer 2 in a total volume of 20 µl. Digestion with EcoRI and HindIII was done in two 
successive steps: the PCR product was first digested with HindIII (with appropriate 





2.2.4.4.1.2.  Analysing DNA fragments by agarose gel electrophoresis 
PCR products or digested plasmids (5-10 µl) were mixed with 6 x DNA loading dye 
(Fermentas) and separated in 0.8-1 % agarose in 1 x TAE contained 1 µg/ml ethidium 
bromide. DNA markers were separated in parallel with the samples. Bands were visualised 
under ultraviolet light illumination and documented using a BioDoc II digital imaging 
system (Biometra). 
 
TAE buffer  
40 mM Tris base 
1 % glacial acetic acid 
1 mM EDTA 
 
2.2.4.4.1.3.  DNA extraction from agarose gels 
DNA was extracted from agarose gels using the QIAquick PCR Purification kit according 
to the manufacturer‘s protocol. Briefly, DNA was separated in a 1 % agarose gel in 1 x 
TAE contained 1 µg/ml ethidium bromide. DNA bands of interest were visualised and 
excised with a scalpel under ultraviolet light illumination. Three volumes of buffer QG 
were then added to 1 volume of the excised gel. The gel was incubated at 50ºC for 10 min 
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(or until the gel was completely dissolved). The mixture was applied to a QIAquick spin 
column placed in a 2-ml collection tube. DNA was bound to the membrane by 
centrifugation at 17,900 x g (13,000 rpm) for 1 min and washed with 750 μl of Buffer PE. 
Finally, DNA was eluted by adding 50 μl buffer EB to the centre of the column and 
collected by centrifugation. 
 
2.2.4.4.1.4.  Vector dephosphorylation 
To avoid vector re-circularisation during cloning, the digested vector was 
dephosphorylated by incubating gel-purified vector with 1 x buffer and 10 U Antarctic 
phosphatase for 1 h at 37
o





2.2.4.4.1.5.  Ligation 
Dephosphorylated vector and insert were mixed in different ratios of vector to insert (1:1, 
1:3, 1:5), and were incubated with 1 µl T4 DNA ligase (400 U), 2 x buffer and ddH2O to 
give a total volume of 20 µl. The ligation reaction was incubated in a thermocycler at 
decreasing temperatures of 22
o
C for 2 h, 18
o
C for 1 h, 14
o
C for 1 h, 10
o
C for 1 h, 6
o
C for 1 
h, and was then incubated at 4
o
C overnight.  The ligation reaction mixture (5 to 7 µl) was 
then transformed into E. coli DH5α. 
 
2.2.4.4.1.6. Transformation 
E. coli DH5α (or BL21) competent cells were thawed on ice for 5 min, mixed carefully 
with 1-50 ng plasmid DNA, and incubated for 30 min on ice. Transformation of 
recombinant plasmid DNA was done by heat shock at 42
o
C for exactly 55 sec to transform 
E. coli DH5α or for 90 sec for transforming ligation reaction mixture (see above) into E. 
coli DH5α. Transformation of recombinant plasmid DNA into E. coli BL21 or E. coli 
BL21 codon plus was performed by heat shock at 42
o
C for exactly 90 sec. After adding 
500 µl of LB medium (without antibiotic), the cells were incubated at 37
o
C for 1 h with 
shaking at 300 rpm. Different amounts of cells were plated (50 µl, 100 µl, 150 µl, and 200 
µl of transformed cells) onto LB plates (with appropriate antibiotics for selection of 
transformants) and the plates were incubated upside down at 37
o
C overnight. 
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LB medium for 1 L LB plate for 1 L  
5 g yeast extract 5 g yeast extract 
10 g NaCl 10 g NaCl 
10 g tryptone 10 g tryptone 
 15 g agar 
 
2.2.4.4.1.7.  Screening transformants 
Selection of positive transformants was done by colony PCR, plasmid digestion or 
sequencing.  Using an inoculation loop, single colonies were picked and stirred in 20 µl of 
20 mM NaOH in a microcentrifuge tube. In order to extract the plasmid, the cells were 
heated for 15 min at 95
o
C and centrifuged at 12,000 rpm for 5 min to completely collect all 
solution. For PCR amplification, the following reaction mixture was set up (final 
concentrations): 1 x buffer, 1.5 mM MgSO4, 0.2 mM of each dNTP, 0.3 µM each primers 
TgEndoG_4_forward and reverse, 5 % (v/v) DMSO, 1 µl plasmid, 0.02 U KOD DNA 
polymerase and ddH2O to give a final volume of 25 µl. The DNA target was amplified as 
follows: (i) denaturation at 95
o
C for 2 min, 45 cycles of (ii) denaturation at 95
o
C for 20 
sec, (iii) annealing at 60
o
C for 10 sec, and (iv) extention at 70
o
C for 15 sec, and (v) a final 
extention at 70
o
C for 5 min, followed by cooling at 4
o
C until the end of the PCR. 
Restriction enzyme digestion of recombinant plasmids was also performed in order to 
confirm transformation with the correct vector. The restriction enzymes used depended on 
the vectors: EcoRI and KpnI for pASK-IBA3 plus, SpHI and HindIII for pQE30, or EcoRI 
and HindIII for pRSET-A. PCR products and digested plasmids were verified by agarose 
gel electrophoresis as described above (see 2.2.4.4.1.2). 
Positive clones were further confirmed by DNA sequencing (Seqlab, Göttingen;T 
www.seqlab.deUT).  
 
2.2.4.4.1.8.  Plasmid extraction 
Selected single colonies were inoculated into 5 ml LB medium supplemented with 
antibiotics for selection of transformants and grown overnight at 37ºC. Plasmid DNA was 
isolated from overnight culture using the GenElute Plasmid Mini Prep Kit according to the 
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manufacturer‘s instructions. Large scale plasmid preparation was achieved by using the 
GenElute Plasmid Maxi Prep Kit as recommended by the manufacturer. 
 
2.2.4.4.1.9.  Preparation of glycerol stocks of bacteria 
Five hundred µl of overnight culture (in LB medium with appropriate antibiotic) was 
gently mixed with 500 µl sterile 87 % glycerol. After approximately 5 min at room 
temperature, cells were transferred to -80
o
C for long-term storage. 
 
2.2.4.4.2. Protein expression 
To express TgEndoG recombinant protein, plasmids were transformed into E. coli BL21 or 
E. coli BL21 codon plus (see above) and cells were selected for ampicillin-resistant 
transformants. Transformants were streaked onto LB plates supplemented with antibiotic 
(ampicillin for BL21 or ampicillin and chlorampenicol for BL21 codon plus). Positive 
colonies were inoculated into 2-5 ml LB medium with appropriate antibiotics and grown 
overnight at room temperature with constant shaking. Overnight cultures were further used 
to inoculate 25-100 ml LB medium with antibiotics and grown at room temperature with 
shaking until reaching an OD600= 0.4-0.6. Protein expression was induced by adding 25 ng 
anhydrotetracycline (for pASK-IBA3 plus) or 1-2 mM IPTG (for pQE30 and pRSET-A). 
Induction was done for 2 hours. Cells were harvested by centrifugation at 4,500 x g for 12 
min at 4
o




2.2.4.4.3. Analysis of protein expression  
Protein expression was assessed by performing SDS-PAGE and protein detection by 
Coomassie blue staining or Western blot analysis.  
 
2.2.4.4.3.1.  Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
Separation of proteins was performed by SDS-PAGE using the Mini Protean 3 (Biorad) 
system; 7.5 % separating gels and 4.4 % stacking gels were used in all experiments. The 
separating gel was prepared as described below, poured into a vertical gel assemble with 
spacers of 0.75 mm, carefully overlaid with isopropanol and allowed to polymerise. 
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Isopropanol was then removed by washing twice with ddH2O and a stacking gel was 
poured onto the separating gel and a comb was inserted. After polymerisation of the gel, 
samples were mixed with 2 x sample buffer and heated for 5 min at 99
o
C in a thermomixer.  
A prestained protein marker was prepared in parallel. Electrophoresis was performed in an 
electrophoresis chamber with 1 x SDS running buffer at a constant current of 25 mA per 
gel. 
 
Separating gel (7.5 %)  Stacking gel (4.4 %)  
0.5 M Tris-HCl (pH 8.8) 0.125 M Tris-HCl (pH 6.8) 
0.1 % (w/v) SDS 0.2 % (w/v) SDS 
7.5 % acrylamide/bisacrylamide  
          (30 %/ 0.8 % w/v) 
4.4 % acrylamide/bisacrylamide  
          (30 %/ 0.8 % w/v) 
0.1 % (w/v) APS 0.04 % (w/v) APS 
0.04 % TEMED 0.4 % TEMED 
 0.004 % (w/v) Bromophenol blue 
  
2x sample buffer 10x SDS running buffer (1 L) 
125 mM Tris-Hcl pH 6.8 0.25 M Tris-HCl 
4 % (w/v) SDS 1.92 M Glycin 
20 % (v/v) glycerol 1 % (w/v) SDS 
65 mM DTT  
0.002 % bromophenol blue  
 
2.2.4.4.3.2.  Coomassie blue staining of proteins separated by SDS-PAGE 
Polyacrylamide gels were fixed in 8.5 % o-phosphoric acid and 20 % absolute methanol 
for 1 h at room temperature with constant shaking. Gels were then submerged in colloidal 
Coomassie blue solutions (see below) at room temperature overnight. After having been 
washed three times (10 min each) in 25 % absolute methanol, gels were soaked in ddH2O. 
The gels were then encased in plastic wraps and dried at room temperature overnight. 
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Colloidal Coomassie blue solution 
20 % absolute methanol 
20 % Roti
®
-Blue solution (Roth) 
60 % ddH2O 
 
2.2.4.4.3.3. Electroblotting of proteins separated by SDS-PAGE 
Proteins separated by polyacrylamide gel electrophoresis were transferred onto a 
nitrocellulose membrane (NC, GE Healthcare) using a semidry blot system. For this 
purpose, the polyacrylamide gel and the NC membrane were placed within a stack of filter 
papers soaked in different transfer buffers as follows (from anode to catode): 6 Whatman 
filter papers soaked with 0.3 M Tris-HCl (pH 10.4) and 20 % methanol, 3 Whatman filter 
papers soaked with 25 mM Tris-HCl (pH 10.4) and 20 % methanol, Hybond nitrocellulose 
membrane, polyacrylamide gel, and 9 Whatman filter papers soaked with 40 mM 6-
aminocapronic acid (pH 7.6) and 20 % methanol. Proteins were transferred to the NC 
membrane at room temperature with a constant current of 0.8 mA/cm
2 
blot area for 1.5 h. 
 
2.2.4.4.3.4. Blocking, washing and antibody incubation 
Transferred proteins were visualised by reversible staining with Ponceau S. Nitrocellulose 
membranes containing transferred protein was put in a petri dish and soaked in 0.1 % (w/v) 
Ponceau S in 5 % (v/v) acetic acid (Sigma-Aldrich) until proteins bands were clearly 
visible. After Ponceau S staining, the NC membrane was washed three times with water. 
For immunoblotting, nonspecific binding sites were blocked and proteins were stained, 
depending on the tag of the fusion protein, as follows. 
For detection of His-tag fusion protein, NC membrane was washed in ddH2O twice (5 min 
each) and was then incubated in blocking solution for 2 h at room temperature or overnight 
at 4
o
C. After having been washed once in washing solution for 5 min, the NC membrane 
was incubated with mouse anti-His-tag antibody (diluted 1:1,000 in blocking solution) for 
2 h at room temperature (or overnight at 4
o
C) and then washed three times 5 min with 
washing solution. Incubation of the NC membrane with anti-mouse IgG HRP-conjugated 
secondary antibody (diluted 1:2,000 in secondary antibody dilution buffer) was done for 
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1.5 h followed by three washing steps (10 min each) with washing solution. Proteins were 
then detected using enhanced chemiluminescence detection (ECL). 
For detection of protein fused to a Strep-tag, NC membrane was washed  twice (10 min 
each) with TBS buffer pH 7.5 and then it was blocked in blocking solution for 1 h at room 
temperature or overnight at 4
o
C. After having been washed twice (10 min each) with TBS-
Tween/Triton and an additional washing step for 10 min with TBS buffer, the NC 
membrane was incubated with mouse anti-Strep-tag antibody (diluted 1:2,000 in blocking 
solution) for 1 h at room temperature (or overnight at 4
o
C) and then washed again as 
above. Immune complexes were then labelled with anti-mouse IgG HRP-conjugated 
secondary antibody (diluted 1:2,000 in secondary antibody dilution buffer) for 1 h. 
Enhanced chemiluminescence detection was performed after washing the NC membrane 
four times (10 min each) with TBS-Tween/Triton. 
 
For detection of His-tag fusion protein  For detection of Strep-tag fusion protein 
Washing solution TBS buffer pH 7.5 
0.05 % Tween-20 10 mM Tris-Cl 
1 x PBS 150 mM NaCl 
  
Blocking solution TBS-Tween/Triton pH 7.5 
5 % dry skimmed milk 20 mM Tris-Cl 
0.2 % Tween-20 500 mM NaCl 
0.02 % sodium azide 0.05 % (v/v) Tween 
1 x PBS 0.02 % (v/v) Triton 
  
Secondary antibody dilution buffer Blocking solution 
5 % dry skimmed milk 3 % BSA (w/v) in TBS 
0.05 % Tween-20  
1 x PBS Secondary antibody dilution buffer 
 10 % (w/v) dry skimmed milk in TBS 
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2.2.4.4.3.5.  Protein Detection 
ECL reagents (GE Healthcare) were mixed 1:2 and used to incubate the membrane for 1 
min. Superfluous solution was removed and the membrane was covered using a transparent 
plastic foil. Protein visualisation was done by exposing the membrane to a 
chemiluminescence imaging device (Luminescent Image Analyzer LAS-4000, Fujifilm). 
Images were recorded either by automatic or increment (up to 1 h) exposure. 
 
2.2.5. Regulation of Toxoplasma PCD 
2.2.5.1.  Detection of ΔΨm 
Intact mitochondrial membrane potential (ΔΨm) is an indicator of vital cells. To label 
mitochondria with an intact ΔΨm, MitoTracker staining was used in this study. To this 
end, 2 x 10
7
 parasites were cultivated in the presence of 10 µM staurosporine or 20 µM 
miltefosine to induce cell death for 24 and 48 h. Non-treated parasites were used as 
controls. The parasites were then isolated by centrifugation at 1,800 x g for 10 min. 
Pelleted cells were resuspended in 500 µl pre-warmed RPMI containing 500 nM 
MitoTracker
®
 Orange CM-H2TMRos for 45 min at 37
o
C. The cells were fixed in 4 % 
paraformaldehyde in 0.1 M sodium cacodylate for 15 min at room temperature and were 
then centrifuged at 1,800 x g for 10 min. After having been washed in 1 x PBS by 
centrifugation as above, pelleted cells were resuspended in 10 µl PBS, mixed with 10 µl 
Mowiol 4-88, spread onto glass slides and covered with glass cover slips. Numbers of 
parasites with an intact mitochondrial membrane potential were counted from at least 500 
cells using a confocal laser scanning microscopy with a 63x oil-immersion objective. 
 
2.2.5.2. In situ measurement of caspase-like activity 
CaspaTag assay, a method for labelling active caspases in situ, and flow cytometry were 
used in this study to determine the involvement of caspase-like proteins in the regulation of 
apoptosis-like cell death in T. gondii. Parasites were cultivated in a 24-well tissue culture 
plate (2 x 10
7
 parasites per well) for 2, 4, 24 and 48 h in the presence of 10 µM 
staurosporine or 20 µM miltefosine to induce cell death. Non-treated parasites were 
processed in parallel and were used as controls. The labelling of active caspase-like 
proteases was performed using the CaspaTag
TM
 Pan-Caspase In Situ Assay Kit, 
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Fluorescein (Chemicon International), following the manufacturer‘s recommendation. 
Briefly, at the indicated time points, 300 µl of each sample were transferred into a 15-ml 
tube and incubated with 10 µl freshly prepared 30 x FLICA solutions for 1 h at 37
o
C under 
5 % CO2. One vial FLICA reagent (a carboxyfluorescein-labelled FAM-VAD-FMK) 
provided in the kit was dissolved in 50 µl DMSO to give a 150 x stock solution. Working 
solution (30 x) was prepared by diluting the stock solution in PBS pH 7.4. After incubation 
with FLICA solution, 2 ml of 1 x wash buffer (diluted from 10 x stock solution provided in 
the kit with ddH20) were mixed with each sample. Cells were then centrifuged at 400 x g 
for 5 min at room temperature. Pelleted cells were resuspended in 1 ml of 1 x wash buffer 
and thereafter were centrifuged again as above. Parasites were then resuspended in 400 µl 
1 x wash buffer. Measurement of caspase labelling was done using flow cytometry 
(FACSCalibur) from 100,000 events.  
 
2.2.5.3.  Impact of proteases during induction of apoptosis-like cell death in T. gondii 
To evaluate the effect of protease inhibitors in the regulation of T. gondii apoptosis-like 
cell death, 2x10
7
 parasites were seeded in a 24-well plate and were incubated in the 
presence of  100 µM Z-VAD-FMK or 100 µM E-64 for 1 h prior to the treatment with 10 
µM staurosporine or 20 µM miltefosine. After 48 h of treatment, the parasites were 
isolated by centrifugation at 1,800 x g for 10 min and pelleted parasites were resuspended 
in 1 ml of 1 x PBS. Parasite solutions (30-50 µl) were then spread onto slides and were 
fixed in 4 % (w/v) paraformaldehyde in 0.1 M sodium cacodylate pH 7.4 for 1 h at room 
temperature. Blocking/permeabilisation were done by incubating cells in 0.1 mg/ml 
saponin and 1 % BSA in PBS and afterwards, parasites were stained with rabbit anti-T. 
gondii antibody and TUNEL as described in section 2.2.2.1. The number of TUNEL-
positive parasites was counted from 500-800 cells using confocal laser scanning 
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2.2.6. Bioinformatics 
The Toxoplasma gondii genome database can be accessed through www.toxodb.org.  Tools 
available in the National Center for Biotechnology Information (NCBI: 
www.ncbi.nlm.nih.gov) or EMBL-EBI (www.ebi.ac.uk) was used for nucleic acid or 
protein alignment. Primer3, a primer design tool, was applied to design primers for DNA 
amplification. Prediction of TgEndoG structure was performed by using PyMOL 
Molecular Graphics System, Version 1.3r1-edu-Win32 Schrödinger, LLC (collaboration 
with Antonio Jiménez-Ruiz, Madrid). MitoProt was used for predicting a mitochondrial 
localisation of TgEndoG and TgBIs. Membrane topology of TgBIs was predicted by using 
several tools: TMHMM2.0, SOSUI, Pfam, MEMSAT_SVM, MEMSAT3, iPSORT, 
SCAMPI, and TopPred 0.01. 
 
2.2.7. Statistical analysis 
Unless otherwise stated, results were depicted as means ± S.E.M. of at least three 
independent experiments. Comparisons were performed by Student‘s t-test; p-values of 
less than 0.05 were considered significant. 
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3.1.  Toxoplasma gondii exhibited markers of apoptosis in response to pro-apoptotic 
stimuli  
Here we describe multiple apoptosis markers which were identified in T. gondii upon 
treatment with pro-apoptotic stimuli. 
 
3.1.1. The occurrence of DNA fragmentation in T. gondii after stimulation of cell 
death 
One biochemical hallmark associated with apoptosis is DNA breakdown (Elmore, 
2007; Popov and Korochkin, 2004). Terminal deoxynucleotidyl transferase-mediated X-
dUTP nick end labelling (TUNEL) assay followed by flow cytometry was used for 
analysing DNA strand breaks in T. gondii following treatment with diverse pro-apoptotic 
stimuli. The TUNEL reaction labels free 3‘-OH termini of DNA fragments occurring 
during apoptosis with fluorochrome-conjugated nucleotides. In our study, H2O2, 
staurosporine, miltefosine, and camptothecin were used to trigger T. gondii death. 
Apoptosis can be induced by reactive oxygen species. It has been described that high 
concentration of H2O2 triggered necrosis whereas low or moderate concentration of H2O2 
induced apoptosis; the effective H2O2 concentration depends on the cell model used for the 
experiments (Troyano et al., 2003). Staurosporine, an alkaloid isolated from Streptomyces, 
is widely used to induce apoptosis. It inhibits a broad spectrum of protein kinases 
(Bertrand et al., 1994). Miltefosine (hexadecylphosphocholine/HePC) was initially used as 
an anticancer drug. Recently, it has been proven as a potent chemotherapeutic agent 
against Leishmania spp.. Miltefosine is able to induce apoptosis in a variety of tumour cell 
lines by affecting membrane fluidity, but the exact molecular mechanism to initiate 
apoptosis remains unclear (Paris et al., 2004). Camptothecin is a DNA topoisomerase I 
inhibitor and effectively acts against a broad spectrum of tumours by initiating apoptosis 
(Liu et al., 2000).  
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To this end, tachyzoites of T. gondii were cultivated in the presence of H2O2, 
staurosporine, miltefosine, or camptothecin for 24 and 48 h. Freshly isolated and mock-
treated parasites were used as controls. At the indicated time points, all samples were 
subjected to TUNEL staining. The number of TUNEL-positives parasites was 
quantitatively measured using flow cytometry (FACS). TUNEL-positive parasites were 
detected in freshly isolated populations (~ 20 %) and this did not significantly increase 
during the next 48 h (Figure 3.1B), indicating a basal level of parasites with considerable 
DNA fragmentation. Parasites treated with pro-apoptotic stimuli displayed a higher 
percentage of TUNEL-positive cells to various extents as compared to freshly isolated and 
mock-treated parasites (Figure 3.1 A,B). Specifically, we observed a significant increase of 
the number of TUNEL-positive parasites after H2O2 treatment (~ 30 % at 48 h post 
treatment; p<0.05), suggesting that reactive oxygen species may induce apoptosis in T. 
gondii. Staurosporine increased the number of TUNEL-positive parasites to approximately 
50 % and this was significantly higher as compared to the freshly isolated and control 
parasites (p<0.01). It indicates that protein phosphorylation may play critical roles in cell 
death regulation in T. gondii. Induction of TUNEL-positive parasites in our study was most 
prominently observed after miltefosine treatment (more than 55 % at 48 h after treatment; 
p<0.01). Camptothecin also induced a significant number of TUNEL-positive parasites of 
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Figure 3.1. DNA fragmentation in extracellular parasites following treatment with pro-apoptotic stimuli was 
detected by TUNEL assay followed by flow cytometry. Extracellular parasites were treated with 2 mM H2O2, 
10 µM staurosporine (Stau), 20 µM miltefosine (HePC), 5 µM camptothecin (CPT), or were mock-treated. 
Freshly isolated parasites were prepared in parallel (0 hrs). A, Parasites were selected based on the FSC/SSC 
dot plots. Representative histograms of parasites treated for 48 h with H2O2, stau or HePC (open histograms) 
or of freshly isolated parasites (filled histograms) are depicted. B, Bars represent means ± S.E.M. Results are 
from 5 – 6 independent experiments (CPT: n = 2).  * p < 0.05; ** p < 0.01.        
                                                      
The strong induction of DNA strand breaks in T. gondii by staurosporine and 
miltefosine prompted us to use these cell death inducers for further experiments. Induction 
of cell death as detected by TUNEL-positive parasites was determined at 0, 6, 24, 48, and 
72 h post staurosporine and miltefosine treatments. The time course experiments showed 
that staurosporine induced DNA fragmentation in a dose- and time-dependent manner. At 
the early time points (up to 48 h post treatment), the number of TUNEL-positive parasites 
between the lower concentration of staurosporine (5 µM) and untreated (mock) parasites 
were not clearly different but it was considerably higher after 72 h of treatment with 5 µM 
staurosporine as compared to control. Induction of DNA strand breaks in T. gondii was 
obviously increased by 10 µM staurosporine from 48 h onwards until 72 h of treatment 
A 
B 
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(Figure 3.2A).  Miltefosine induced DNA fragmentation more rapidly than after 
staurosporine treatment. Increased levels of TUNEL-positive parasites were already clearly 
observed at 24 h post treatment and further increased thereafter (Figure 3.2B). 
 
Figure 3.2. Kinetics of DNA fragmentation in T. gondii upon cell death induction by staurosporine or 
miltefosine as detected by TUNEL assay and flow cytometry. Extracellular parasites were treated with 5 µM 
or 10 µM staurosporine (Stau), 20 µM miltefosine (HePC), or were mock-treated for up to 72 h. Data 
represents means ± S.E.M.  from at least three independent experiments.  
 
Together, the results indicated that DNA strand breaks, a hallmark of apoptosis, 
could be induced in T. gondii following treatment with common pro-apoptotic stimuli. 
 
3.1.2. Cell size reduction in extracellular parasites after treatment with pro-
apoptotic stimuli 
Various morphological changes occur during apoptosis including cell shrinkage, i.e. 
pyknosis (Kerr et al., 1972). To investigate alteration in parasite size upon cell death 
induction, the means of the forward scatter (FSC) value as obtained by flow cytometry 
analysis of freshly isolated, untreated and treated parasites were compared; reduction in 
FSC value implied a decrease in cell size.  
Our data showed that a reduction in cell size was observed in staurosporine- and 
miltefosine-treated parasites (Figure 3.3A). Staurosporine treatment led to a reduction of 
parasite size in a dose- and time-dependent fashion as likewise observed after TUNEL 
staining (see above) (Figure 3.3A). Such cell size reduction was clearly observed at 72 h 
post treatment. However, the reduction in cell size was more rapidly and more strongly 
detected in miltefosine-treated parasites (Figure 3.3A) that also displayed the highest 
percentage of TUNEL-positive parasites.  
A B 
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Figure 3.3. Reduction of the parasite cell size and alterations of the morphology of T. gondii following 
treatment with pro-apoptotic stimuli were assessed by flow cytometry and immunofluorescence microscopy. 
Parasites were treated with 5 µM or 10 µM staurosporine (Stau), 20 µM miltefosine (HePC) or were mock-
treated. A, Comparison of the parasite cell size between samples was based on the FSC value of FACS data 
analysis. Data represents means ± S.E.M.  from at least three independent experiments. B, Images are 
representative of freshly isolated (0 hrs), mock-treated, staurosporine (Stau)- or miltefosine (HePC)-treated 
parasites that have been stained with parasite-specific antibodies (red) and TUNEL reaction mix (green) at 48 
h of treatment. C, Representative images of mock-treated or miltefosine (HePC)-treated parasites at 48 h post 
treatment as obtained by confocal laser scanning microscopy with high magnification clearly showed 
TUNEL-positive parasites after HePC treatment with a reduction in cell size. DIC, differential interference 
contrast. D, Hoechst staining (blue) of parasites treated with miltefosine (HePC) for 48 h confirmed the 
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To further confirm and extend the results of TUNEL assay and flow cytometry, we 
performed TUNEL assay followed by confocal laser scanning microscopy. Parasites that 
had been treated or not with pro-apoptotic stimuli were stained with antibodies against T. 
gondii (red labelling) and thereafter were subjected to TUNEL staining (green labelling). 
Using confocal laser scanning microscopy, we observed the occurrence of DNA strand 
breaks in approximately 9 % of freshly isolated and control parasites (data not shown). A 
strong increase in the number of TUNEL-positive parasites was detected following 
treatment with pro-apoptotic stimuli (~ 40 % and ~ 35 % at 48 h post staurosporine and 
miltefosine treatment, respectively; Figure 3.3B). Moreover, TUNEL-positive tachyzoites 
showed morphologically a reduction in cell size; they became smaller and round in 
comparison to TUNEL-negative parasites that maintained their crescent shape (Figure 
3.3B,C). To counterstain the nuclei of parasites, Hoechst 33258 (blue fluorescence) was 
applied after TUNEL staining. The results clearly confirmed a colocalisation of TUNEL 
labelling and Hoechst 33258 staining (Figure 3.3D, arrows), showing that DNA strand 
breaks occurred within the parasite nuclei. 
Thus, we provided evidence that rounding-up of the cell and reduction of the cell 
volume, which are characteristic features of cells undergoing apoptosis, were also detected 
in T. gondii after treatment with pro-apoptotic stimuli. 
 
3.1.3. Treatment with staurosporine, but not HePC, triggered TUNEL-positivity in 
intracellular parasites 
To identify whether T. gondii would undergo apoptosis in the natural environment, 
i.e. intracellularly, confluent HFF cells were infected with tachyzoites of T. gondii for 24 h 
prior to treatment with staurosporine or miltefosine and then further incubated for up to 24 
h. At 3, 6, and 24 h post treatment, the cells were fixed in paraformaldehyde and stained 
with parasite-specific antibodies and were subjected to TUNEL staining. The presence of 
TUNEL-positive intracellular parasites was then visualised by confocal laser scanning 
microscopy. 
Staurosporine strongly triggered DNA strand breaks in 44.3 % and 48.9 % of 
intracellular parasites at 3 and 6 h post treatment, respectively. Since HFF cells were also 
affected by staurosporine (Figure 3.4, arrow) the occurrence of TUNEL-positive 
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intracellular T. gondii could not be followed beyond the time point of 6 h of treatment. In 
contrast, miltefosine did not strongly induce DNA strand breaks in intracellular parasites 
(0.6 and 0.5% at 3 and 6 h after treatment, respectively; data not shown). Although 
TUNEL-positive intracellular parasites were not regularly detected in mock-treated cells, 
we also observed occasionally TUNEL-positive intracellular control parasites (data not 
shown).  
This result established that treatment of intracellular T. gondii with a well-known 
pro-apoptotic stimulus, i.e. staurosporine, induces significant levels of DNA fragmentation, 
i.e. a hallmark of apoptosis. 
 
Figure 3.4.  DNA fragmentation in intracellular parasites after treatment with staurosporine. Images represent 
staurosporine (stau)-treated or mock-treated T. gondii-infected HFF cells at 3 h post treatment. Note the 
appearance of TUNEL-positive intracellular parasites (arrowheads) and TUNEL-positive HFF cells (arrow). 
Differential interference contrast (DIC) images are included to assure intracellular location of the parasites. 
 
3.1.4. T. gondii displayed phosphatidylserine externalization following treatment 
with pro-apoptotic stimuli 
An important biochemical feature of apoptosis is phosphatidylserine (PS) exposure. 
Phosphatidylserine, a component of the cell membrane, is translocated from the inner 
leaflet to the outer leaflet of the plasma membrane during early stages of apoptosis; such 
PS-exposing cells are still viable (Martin et al., 1995; Zimmermann et al., 2001). The 
exposure of PS can be quantitatively detected using Annexin V, a Ca
2+
-dependent 
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phospholipid binding protein with high affinity for PS (Vermes et al., 1995). 7-Amino-
actinomycin (7-AAD), a standard flow cytometry viability probe, was included to 
distinguish between apoptotic and necrotic cells. Viable cells will exclude 7-AAD, 
whereas the membranes of dead and damaged cells are permeable to 7-AAD. Cells which 
undergo apoptosis will thus be stained positive for Annexin V-PE and negative for 7-AAD.  
To this end, tachyzoites of T. gondii were incubated with staurosporine, miltefosine 
or were mock-treated for 24 and 48 h. At the indicated time points, parasites were collected 
by centrifugation and were then incubated with Annexin V and 7-AAD. The stained cells 
were then subjected to flow cytometry. The results showed that approximately 5 % of 
mock-treated parasites exposed PS on their cell membrane (Figure 3.5). Treatment of 
parasites with staurosporine and miltefosine resulted in a higher percentage of Annexin V 
positive/7-AAD negative cells at 24 and 48 h post treatment as compared to control 
parasites (Figure 3.5).  Translocation of PS significantly increased at 24 h post 
staurosporine and miltefosine treatment with ~ 12 % and ~ 17 % of the cells being positive, 
respectively (p<0.01). This further increased slightly until 48 h after miltefosine treatment 
(p<0.01). Importantly, only minor percentages of 7-AAD positive cells were detected 
among control parasites and those treated with pro-apoptotic stimuli during the observation 
period (~ 2 to 3 %; data not shown). This excluded the induction of necrosis following pro-
apoptotic treatment of T. gondii. 
 
Figure 3.5. Translocation of phosphatidylserine (PS) after staurosporine or miltefosine treatment. The 
percentages of parasites which exposed PS on the outer leaflet of their plasma membrane after treatment with  
staurosporine (stau) or miltefosine (HePC) or mock treatment were assessed using Annexin V/7-AAD 
staining and by flow cytometry. Representative flow cytometry dot plots (A) and comparison between 
samples for the emergence of Annexin V-positive/7-AAD-negative parasites (B) are depicted. Bars represent 
means ± S.E.M. from four independent experiments. ** p < 0.01.  
A B 
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Together, the data strongly indicated that following treatment with pro-apoptotic 
stimuli, T. gondii undergo a form of programmed cell death that shows characteristic 
features of apoptosis as observed in metazoan. 
 
3.1.5. Pre-treatment of extracellular parasites with pro-apoptotic stimuli diminished 
parasite invasiveness 
 To evaluate whether extracellular parasites preserve their invasion ability after 
being pre-incubated with pro-apoptotic stimuli, extracellular tachyzoites were pre-treated 
with staurosporine or HePC or were mock-treated for 48 h and thereafter the parasites were 
used to inoculate confluent HFF cells. At 24 and 48 h of infection, cells were fixed and 
stained using parasite-specific antibodies and were then analysed using confocal laser 
scanning microscopy. The numbers of parasitophorous vacuoles (PV) were determined 
from 10 randomly selected visual fields. The results showed that untreated parasites were 
still able to invade HFF cells and to replicate as shown by the increasing sizes of 
parasitophorous vacuoles over time and numerous PVs per visual field (Figure 3.6A,B). A 
possible explanation for the survival of untreated tachyzoites in the extracellular milieu is 
that tachyzoites of T. gondii form mRNA aggregates with characteristics of stress granules 
(SG). The SG formation occurs when cells encounter environmental stress and it improves 
the fitness of extracellular parasites (Lirussi and Matrajt, 2011). Conversely, parasites 
which had been pre-treated with 10 µM staurosporine or 20 µM miltefosine lost their 
invasiveness; they resided extracellularly and were not able to invade host cells (Figure 
3.6A). This indicated that extracellular parasites undergoing apoptosis might not be able to 
sustain a productive infection. 
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Figure 3.6. Pre-treatment of extracellular parasites with pro-apoptotic stimuli abrogate the ability of T. gondii  
to invade HFF cells. Extracellular parasites were pre-treated with 10 µM staurosporine (stau) or 20 µM 
miltefosine (HePC) or were mock-treated for 48 h prior to inoculation of confluent HFF cells. After 24 and 
48 h of infection, cells were fixed and parasites were stained with parasite-specific antibodies. A, Images are 
representative of HFF cells that were inoculated for 48 h with parasites which had been treated with 
staurosporine and miltefosine as obtained by confocal laser scanning microscopy. DIC, differential 
interference contrast. B, Numbers of parasitophorous vacuoles (PVs) were determined from 10 randomly 
selected visual fields from each sample. Bars represent the average numbers of PV per visual field. Data is 
from 1 experiment. 
 
3.2. Physiological significance of apoptosis-like cell death in T. gondii 
There are an increasing number of reports on the existence of apoptosis-like cell 
death in single-celled organisms. Putative benefits of a self-destruction ability for 
protozoan parasites have been proposed to be the regulation of parasite densities, the 
evasion of immune responses of the host, the regulation of differentiation processes in 
parasites, and a counter mechanism under stress conditions in order to ensure perpetuation 
of infection (Al-Olayan et al., 2002; Ameisen et al., 1995; Bruchhaus et al., 2007; 
Duszenko et al., 2006; van Zandbergen et al., 2006; van Zandbergen et al., 2010).  
In this study, we performed experiments to unravel the physiologic relevance of an 
apoptosis-like cell death in T. gondii. 
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3.2.1. TUNEL-positive parasites were observed during chronic infection with T. 
gondii, but not during acute infection 
  The tachyzoite is the rapidly replicating stage of T. gondii and contributes to acute 
inflammation during T. gondii infection (Dubey et al., 1998; Kim and Weiss, 2004; 
Laliberte and Carruthers, 2008). A chronic infection of T. gondii is characterised by the 
presence of bradyzoites, a slow growing stage, within tissue cysts. The cysts contain 
hundreds or more bradyzoites and may persist for years without harming the host (Dubey 
et al., 1998; Pavesio et al., 1992).  
  To evaluate the appearance of an apoptosis-like cell death during the natural life 
cycle of T. gondii, mice (strain NMRI) were inoculated by defined amounts of parasites i.p. 
and the intraperitoneal fluid was isolated at 7, 10, and 12 days post infection. After fixing 
and permeabilising the intraperitoneal cells, the parasites were stained using antibodies 
against T. gondii and subsequently were stained by TUNEL assay. The results indicated 
that TUNEL-positive parasites were not prevalent during acute intraperitoneal 
inflammation at 7, 10 and 12 days post infection (Figure 3.7A).  It suggests that apoptosis-
like cell death did not contribute to the regulation of tachyzoite density during acute 
infection in the peritoneal cavity of infected mice.  
  We furthermore tested whether apoptosis-like cell death occurs during chronic 
infection. For this purpose, NMRI mice were infected intraperitoneally by T. gondii tissue 
cysts (kindly provided by Dirk Schlüter, Magdeburg). After ~ 30 weeks, brains from 
Toxoplasma-infected NMRI mice were isolated and homogenised by glass beads.  The 
homogenised solution was then spread onto glass slides and fixed with methanol.  Staining 
with antibodies recognizing bradyzoites of T. gondii within the brain cysts and 
concomitant TUNEL assays showed the appearance of TUNEL-positive bradyzoites within 
tissue cysts. Bradyzoites with TUNEL-positive feature were diffusely distributed within 
the tissue cysts (Figure 3.7B); no particular localisation, for example along the line of the 
cyts wall, was detected. Importantly, we could not detect the presence of TUNEL-positive 
parasites in young tissue cysts (consisting of only few bradyzoites). Thus, the results 
indicated that T. gondii employs an apoptosis-like cell death during chronic infection; it 
possibly depends on the age of the tissue cysts.   
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Figure 3.7. TUNEL-positive bradyzoites were detected during chronic infection of T. gondii. Mice were 
intraperitoneally inoculated with a defined amount of tachyzoites (for establishment of acute infection) or 
with a defined number of cysts (for development of chronic infection). A, At 7, 10, and 12 days post 
inoculation (p.i) with tachyzoites, intraperitoneal fluid was collected and then labelled using polyclonal T. 
gondii-specific antibodies and TUNEL reaction mix. B, Brains from chronically infected mice (~ 30 weeks 
p.i) were isolated, homogenised and then stained using DC11 antibodies (bradyzoite-specific labelling) and 
TUNEL reaction mix. TUNEL-positive parasites (green labelling) were not observed during acute 
inflammation (A) but were recognised during chronic infection (B).  
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3.2.2. An apoptosis-like cell death occurred after treatment of tachyzoites with 
chemotherapeutic drugs commonly used against toxoplasmosis 
To determine whether T. gondii would undergo an apoptosis-like cell death under 
drug treatment, confluent HFF cells were inoculated with tachyzoites and were then treated 
with common drugs to treat toxoplasmosis. Parasites were labelled with parasite-specific 
antibodies and were subjected to TUNEL assay, and were analysed by confocal laser 
scanning microscopy.  
The results showed a significant reduction of parasite replication following 
treatments of T. gondii with anisomycin, atovaquone or pyrimethamine as compared to the 
control treatment (p<0.01; Figure 3.8A). At 48 h post treatment, numbers of parasites per 
PV decreased from ~ 8 in untreated parasites to ~ 2-4 in treated parasites. Because of its 
delayed parasiticidal effect (Fichera et al., 1995; Pfefferkorn et al., 1992), clindamycin 
effectively inhibited parasite replication only during the second but not the first replication 
cycle (Figure 3.8A; p<0.01). Remarkably, the number of TUNEL-positive extracellular 
parasites increased after treatment with all chemotherapeutics for 48 h as compared to the 
control with the strongest increase being induced using atovaquone (p<0.05) (Figure 3.8B; 
Figure 3.8C, arrowheads). Most importantly, a significant number of intracellular parasites 
which were strongly TUNEL-positive were also recognised during the second cycle of 
clindamycin treatment (Figure 3.8D; p<0.01). TUNEL-positive intracellular parasites 
following clindamycin treatment showed an abnormal morphology (Figure 3.8C, arrows).  
This data indicates that an apoptosis-like cell death can be triggered in extracellular and 
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Figure 3.8. Induction of an apoptosis-like cell death in extracellular and intracellular T. gondii under drug 
treatments. Parasite-infected HFF cells were treated with 500 nM anisomycin, 100 nM atovaquone, 1 µM 
pyrimethamine or 500 nM clindamycin (clinda; for two consecutive cycles of parasite replication) or were 
mock-treated. After 48 h of treatment, parasites were stained using parasite-specific antibodies (red 
fluorescence) and DNA strand breaks were detected by in situ TUNEL assay (green fluorescence). A, 
Parasite replication was determined by calculating the average number of parasites per parasitophorous 
vacuole (PV). Bars represent means ± S.E.M. from three independent experiments. B,D, TUNEL-positive 
extracellular (B) and intracellular (D) parasites. Bars represent means ± S.E.M. from three independent 
experiments. C, Representative images of cells treated with the indicated drugs for 48 h were obtained by 
confocal laser scanning microscopy. TUNEL-positive extracellular parasites are marked by arrowheads 
(atovaquone), TUNEL-positive intracellular parasites are marked by arrows (second cycle of clindamycin 
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3.3. Molecules which may be responsible for the regulation of apoptosis-like cell 
death in T. gondii  
Since molecules which might regulate or execute apoptosis-like cell death in T. 
gondii are yet unknown, experiments were conducted in order to unravel possible cell 
death pathways in T. gondii. 
 
3.3.1. Up-regulation of cell death-associated genes following treatment of T. gondii 
with pro-apoptotic stimuli 
Apoptosis is a highly complex and sophisticated mechanism, involving numerous 
components of the cell death machinery (Elmore, 2007; Vaux and Strasser, 1996). In order 
to identify putative cell death-associated molecules in T. gondii, a text-based in silico 
analysis of the T. gondii genome database (www.toxodb.org) was conducted. Seventeen 
cell death-associated genes were identified from the database, including a putative 
endonuclease G (TgME49_008710), a putative apoptosis inducing factor (AIF; 
TgME49_007620), a putative metacaspase (TgME49_006490), putative Bax inhibitors 
(hypothetical proteins; TgME49_049770, TgME49_109560 and TgME49_003030), 
putative calpains (TgME49_093820 and TgME49_093830), beclin-1 (TgME49_021360), 
putative ICE-like protease (TgME49_078970), putative ELMO-like protein 
(TgME49_053000), putative programmed cell death proteins (TgME49_094420 and 
TgME49_105490), a putative defender against cell death (DAD; TgME49_105870), a 
putative apoptosis-regulating basic protein (TgME49_035880), and other hypothetical 
proteins (TgME49_035560 and TgME49_107780) (Table 3.1).  
 
Table 3.1. Toxoplasma gondii cell death-associated genes 
Gene ID Name Annotation 





hydrolase activity/metal ion 
binding 
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TgME49_053000 ELMO/CED12 family domain-
containing protein 
phagocytosis 
   
TgME49_094420 Programmed cell death protein, 
putative 
no further information 
   





   
TgME49_093830 Calpain, putative metabolic 
process/methyltransferase 
activity 
   
TgME49_021360 Beclin-1, putative autophagy 
   
TgME49_049770 Hypothetical protein, conserved Homologue of TgVEG ‗Fas 
apoptotic inhibitory molecule, 
putative‘ 
   
TgME49_109560 Hypothetical protein, conserved Homologue of TgVEG ‗Fas 
apoptotic inhibitory molecule, 
putative‘ 
   
TgME49_003030 Hypothetical protein Homologue of TgVEG ‗Fas 
apoptotic inhibitory molecule, 
putative‘ 
   
TgME49_105490 Programmed cell death protein, 
putative 
no further information 
   
TgME49_105870 Dolichyl-
diphosphooligosaccharide-
protein glycotransferase, putative 
Homologue of TgGT1, TgVEG 
‗defender against cell death, 
putative‘ 
   
TgME49_035560 Hypothetical protein activation of caspase 
activity/protein 
binding/induction of apoptosis 
   
TgME49_107780 Hypothetical protein proteolysis/calcium-dependent 
cysteine-type endopeptidase 
activity 
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TgME49_035880 Apoptosis-regulating basic 
protein, putative 
no information  
   






To examine the expression levels of the selected genes upon induction of apoptosis, 
total RNA from staurosporine- and miltefosine-induced parasites as well as from control 
parasites was extracted followed by cDNA synthesis. Using a set of primer pairs for the 
selected genes (Chapter 2, section 2.1.7, Table 2.5), the expression level of these genes was 
measured through quantitative real-time reverse transcriptase PCR. These analyses 
revealed that transcripts of all of the selected genes were detected in freshly isolated 
parasites and that their expression did not change until 48 h of mock treatment (Figure 
3.9A,B). 
Following staurosporine treatment,  several mRNAs of the seventeen selected 
genes increased in a time-dependent fashion (Figure 3.9A). The strongest up-regulated 
transcript was PDCD2 (TgME49_105490), which increased 100-fold at 48 h post 
staurosporine treatment. A strong up-regulation of mRNAs at 48 h after staurosporine 
treatment was also detected for putative ELMO (TgME49_053000) and DNA/RNA 
endonuclease (TgME49_008710) transcripts which both increased more than 20-fold, a 
putative Fas apoptotic inhibitory molecule (hypothetical protein; TgME49_049770) which 
increased 18-fold and two calpain-like proteins (TgME49_093820 and TgME49_093830) 
which increased more than 10-fold. Treatment with miltefosine also strongly up-regulated 
the transcript of PDCD2 (more than 40-fold at 48 h) while other transcripts were only 
moderately up-regulated or even not regulated (Figure 3.9B). 
Together, the data suggested that components of ancient PCD machinery may exist 
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Figure 3.9. Transcript levels of T. gondii putative PCD-associated genes after treatment of parasites with pro-
apoptotic stimuli. Parasites were treated with 10 µM staurosporine (stau) or 20 µM miltefosine (HePC), or 
were mock-treated for 24 h (cross-hatched bars) and 48 h (black bars). After RNA isolation and reverse 
transcription, cDNA was amplified by quantitative real-time PCR using specific primer pairs for the 
indicated cDNAs or actin of T. gondii. Results are described as the mean ratios (x-fold) ± S.E.M. (n = 3) of 
the mRNA after treatments as compared to freshly isolated parasites and are normalised to actin. 
 
 Considering that T. gondii do not express genuine caspases, we further focused in 
our study on T. gondii Bax inhibitors (TgBIs) and Endonuclease G (TgEndoG). Both 
proteins are considered to play roles in ancient PCD pathways. 
 
3.3.2. Toxoplasma gondii Bax inhibitors (TgBIs) 
3.3.2.1. Bioinformatic analysis 
In silico analysis of the T. gondii genomic database demonstrated the presence of 
three putative Bax inhibitor genes, named T. gondii Bax inhibitor-1, -2, and -3 (TgBI-1, 
A 
B 
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TgBI-2 and TgBI-3). Amino acid sequence analysis of TgBI-1, TgBI-2 and TgBI-3 
showed 33-38 % identity with human BI-1. Putative TgBI-1, TgBI-2 and TgBI-3 contain 
6-9 transmembrane (TM) domains and have a predicted molecular weight of 37,974 Da, 
29,322 Da and 37,345 Da, respectively (Table 3.2). Conserved C-terminal charged residues 
EAVNKK in human Golgi Anti-Apoptotic Protein (hGAAP) or EKDKKEKK in human 
Bax Inhibitor 1 (hBI-1) which are important for their anti-apoptotic, cell adhesion and 
calcium regulatory functions (Carrara et al., 2012) could not be identified in TgBIs; TgBIs 
showed no conserved domains that could be used to predict their molecular function. 
 
Table 3.2. Characteristics of TgBIs  
Name/ID Amino acids Tool TM domain
1
 
TgBI-1 339 TMHMM2.0 9 
TgME49_049770  SOSUI 9 
  Pfam 9 
   MEMSAT_SVM 7 
   MEMSAT3 6 
   SCAMPI 9 
   TopPred 0.01 9 
    
TgBI-2 265 TMHMM2.0 7 
TgME49_109560  SOSUI 7 
  Pfam 7 
   MEMSAT_SVM 7 
   MEMSAT3 6 
   SCAMPI 7 
   TopPred 0.01 7 
    
TgBI-3 342 TMHMM2.0 7 
TgME49_003030  SOSUI 7 
  Pfam 7 
   MEMSAT_SVM 7 
   MEMSAT3 7 
   SCAMPI 7 
   TopPred 0.01 7 
 
1
The membrane topology of TgBIs was predicted using different tools as indicated above. Data showed 
different predicted numbers of transmembrane (TM) domains of TgBIs.  
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3.3.2.2. Immunofluorescence assay of T. gondii Bax inhibitors demonstrated distinct 
localisations of the proteins 
Coding sequences encoding TgBI-1, -2 and -3 (kindly provided by Dominique 
Soldati-Favre, Geneva) have been subcloned into the mammalian expression vectors 
pCMV-SC-NF or pCMV-SC-CF. These vectors contain an N- or C-terminal FLAG-tag 
that allows the detection of recombinant protein. To unravel possible functions of T. gondii 
BI proteins in the regulation of apoptosis, TgBIs coding genes were heterologously 
expressed in HeLa cells. HeLa cells are widely used to investigate apoptosis mechanisms, 
therefore we used HeLa cells in these experiments as a model to analyse the TgBIs 
function. Stable transfection of the genes encoding TgBI-1, TgBI-2 and TgBI-3 into HeLa 
cells was confirmed by immunofluorescence microscopy. 
Detection of expression and localisation of the recombinant TgBIs was performed 
by immunofluorescence assay (Figure 3.10). To this end, wildtype (WT) HeLa cells and 
TgBIs-expressing HeLa cells were seeded in a 24-well plate containing cover slips. After 
24 h, cells were fixed and stained with anti-FLAG antibodies and were then visualised 
using a confocal laser scanning microscopy. Interestingly, the result showed clear 
differences in the localisations of the different TgBIs; TgBI-1 had a perinuclear 
localisation, TgBI-2 had a predominant cell surface expression and TgBI-3 had both a 
perinuclear and cell surface localisation. 
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Figure 3.10. Expression and localisation of TgBIs in HeLa cells was detected by immunofluorescence 
microscopy. Detection of recombinant proteins of TgBI-1 (clone 22), TgBI-2 (clone 23) and TgBI-3 (clone 
12) was performed using anti-FLAG and fluorescently labelled secondary antibodies (green fluorescence). 
Propidium iodide (PI; red fluorescence) is a DNA-binding dye. It was used to stain the nuclei and to visualise 
the whole cell population. Images were obtained by confocal laser scanning microscopy.  
 
3.3.2.3. TgBIs showed a non-mitochondrial localisation 
 Bax inhibitor-1 is an evolutionary conserved protein that mainly localises to ER 
membranes, but can also be detected in mitochondria (Chae et al., 2004; Xu and Reed, 
1998). Moreover, Leishmania Bax inhibitor has been found in mitochondria (Antonio 
Jiménez-Ruiz, Madrid; personal communication).  To determine whether heterologously 
expressed TgBIs also have a mitochondrial localisation, Mitotracker (a mitochondria 
probe) co-staining was used in our study. 
To this end, Hela WT and TgBIs-expressing HeLa cells were seeded on cover slips 
in a 24-well plate. After 24 h, cells were incubated with Mitotracker dye and then 
immunofluorescently labelled using an anti-FLAG antibody. TgBIs (either TgBI-1, TgBI-
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2, or TgBI-3) did not colocalise with characteristic mitochondria (Figure 3.11), indicating 
that TgBIs have a non-mitochondrial localisation. 
Detection of the protein localisation is important because the localisation of a 
protein and its physiological function are closely related (Bolte and Cordelieres, 2006). 
Therefore, an approach using well-characterised organelle markers is required to precisely 
visualise the location of TgBIs.  
 
Figure 3.11. Heterologous expression of TgBIs in HeLa cells showed a non-mitochondrial localisation as 
detected by MitoTracker and anti-FLAG co-staining. HeLa cells transfected with TgBI-1 (clone 22), TgBI-2 
(clone 23) or with TgBI-3 (clone 12) or HeLa WT cells were grown on round cover slips in a 24-well plate. 
After staining with MitoTracker® Orange CM-H2TMRos, the cells were fixed and were then stained with 
anti-FLAG antibodies. Visualisation of the cells was done using confocal laser scanning microscopy. Images 
of both labellings were sequentially recorded in order to avoid a crosstalk between MitoTracker (red 
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3.3.2.4. Redistribution of TgBIs upon cell death induction 
To evaluate the effect of cell death inducers on the cellular distribution of TgBIs, 
we incubated Hela WT, TgBI-2- and TgBI-3-transfected HeLa cells (stable transfectants of 
TgBI-1 have not yet been obtained when we performed this experiment) in the presence of 
staurosporine or brefeldin A (breA). Staurosporine has been widely used to induce 
apoptosis in various cell types, but the mechanism to initiate apoptosis remains largely 
undefined. Staurosporine has been described to induce apoptosis in melanoma cells by 
both caspase-dependent and caspase-independent pathways (Zhang et al., 2004). Brefeldin 
A is a fungal antibacterial agents that blocks transport of newly synthesised proteins from 
ER to the Golgi apparatus, but not the retrograde transport of proteins back to the ER 
(Lippincott-Schwartz et al., 1989; Miller et al., 1992). After treatments with staurosporine 
and brefeldin A for 24 and 48 h, the HeLa cells and TgBIs-expressing HeLa cells were 
fixed, then stained with anti-FLAG antibodies and analysed using confocal laser scanning 
microscopy.  
Following staurosporine treatment, TgBI-2 protein maintained its predominant cell 
surface localisation (Figure 3.12). However, the protein redistributed to the cytosol and lost 
the cell surface expression after brefeldin A treatment. On the other hand, TgBI-3 protein 
lost its perinuclear and cell surface expression during both treatments with different 
characteristics; staurosporine led to a rather diffuse localisation of TgBI-3 within the 
cytosol while brefeldin A treatment caused a punctate pattern of the protein within the 
cytosol. The results suggested the existence of distinct mechanisms of Bax inhibitor 
proteins to respond to different stimuli of cell death. 
Chapter 3 Results 
 
Page | 70  
 
 
Figure 3.12. Redistribution of TgBI-2 and TgBI-3 following staurosporine or brefeldin A treatment. HeLa 
cells transfected with TgBI-2 (clone 23) or with TgBI-3 (clone 12) or HeLa WT cells were grown on round 
cover slips in a 24-well plate and were then treated with 0.3 µM staurosporine (stau) or 10 µM brefeldin A 
(breA) or were left untreated (control). Images represent TgBI-2 and TgBI-3 localisation at 24 h post 
treatment. The upper panel shows representative images of TgBI-2-transfected HeLa cells and the lower 
panel those of TgBI-3-transfected HeLa cells. Images were recorded by confocal laser scanning microscopy 
after labelling of TgBIs with anti-FLAG antibodies (green fluorescence) and propidium iodide staining (red 
fluorescence). Note the different distributions of the proteins following treatment with pro-apoptotic stimuli. 
 
3.3.2.5. TgBIs in HeLa cells partially inhibited caspase 3/7 activity following cell 
death induction 
Caspases are activated during apoptosis induction in mammalian cells. To 
determine whether caspases are activated in TgBIs-transfected HeLa cells upon cell death 
stimulation, we performed a caspase activity assay using a fluorescently labelled synthetic 
substrate, DEVD-AMC (a substrate of caspase 3 and 7). The substrate will be cleaved in 
the presence of active caspases and the released fluorochrome will fluoresce. The caspase 
activity was assessed by calculating the increase of fluorescence intensity in cellular 
lysates from 5 to 60 min. 
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To this end, HeLa WT and TgBIs-expressing HeLa cells were seeded and incubated 
for 24 and 48 h in cell culture medium containing staurosporine and brefeldin A. Total 
soluble proteins were collected by lysing the cells and centrifugation. Measurement of 
caspase 3/7 activity revealed an inhibitory effect of TgBI-1 as well as TgBI-2 in HeLa cells 
after treatment with staurosporine and of TgBI-2 after brefeldin A treatment (Figure 3.13). 
Additionally, TgBI-2 also showed a protective effect against cell death induction in HeLa 
cells following treatment with 5 µg/ml tunicamycin, an N-glycosidic linkage blocker, at 24 
and 48 h post treatment and following treatment with 2 µM thapsigargin, an endoplasmic 
reticulum calcium pump inhibitor, at 48 h post treatment (data not shown).  In contrast, 
heterologous expression of TgBI-3 in HeLa cells did not inhibit caspase activity following 
both staurosporine and brefeldin A treatments (Figure 3.13). The results suggested a 
conserved ability of TgBIs to partially inhibit apoptosis which is in mammals executed via 
a caspase cascade.  
 
Figure 3.13. Measurement of caspase 3/7 activity partially revealed an inhibitory effect of TgBI-1 and TgBI-
2, but not TgBI-3, on apoptosis induction in HeLa cells after treatment with staurosporine and brefeldin A. 
HeLa WT and distinct clones of TgBIs-expressing HeLa cells (TgBI-1-22, TgBI-2-23 and TgBI-3-12) were 
cultivated in the presence of 0.3 µM staurosporine (stau) or 10 µM brefeldin A (BreA) of were left untreated 
(control). At 24 and 48 h, total soluble proteins were collected by lysing the cells. Caspase activity in cellular 
lysates was determined by measuring the fluorescence intensity after cleavage of a fluorochrome-conjugated 
synthetic substrate, DEVD-AMC. Bars represent means ± S.E.M. from three experiments of TgBI-1 (upper 
panel), TgBI-2 (middle panel) and TgBI-3 (lower panel). Caspase activities after 24 h of treatment are 
depicted as black bars and those from 48 h post treatment are depicted as open bars. 
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3.3.2.6. TgBIs in HeLa cells reduced the induction of hypoploid DNA following pro-
apoptotic treatments 
During apoptosis, DNA is fragmented and partially lost from the apoptotic nuclei 
due to the formation of apoptotic bodies, resulting in hypoploid nuclei (expressed as sub 
G0/G1 peak) (Krysko et al., 2008). To quantitatively measure apoptotic nuclei in TgBIs-
expresssing HeLa cells, propidium iodide (a fluorescent dye that binds to nucleic acids) 
staining and flow cytometry have been performed.  
For this purpose, HeLa and TgBIs-expressing HeLa cells were grown and treated 
with staurosporine or brefeldin A or were left untreated for 24 and 48 h. To remove 
contaminating RNA, RNA was digested using RNase A prior to staining the nuclei using 
propidium iodide. Stained cells were then analysed by flow cytometry.  
Heterologous expression of TgBI-1 led to a significant reduction in the appearance 
of cells with sub G0/G1 nuclei as compared to control HeLa WT cells at 24 h after 
treatment with brefeldin A (Figure 3.14B; p<0.01). Following staurosporine treatment, 
TgBI-1 showed a slight reduction of hypoploid DNA at 48 h post treatment. TgBI-2 
exhibited a trend to reduce the induction of hypoploid DNA after treatment with both 
stimuli (Figure 3.14 A,C). TgBI-3 in HeLa cells showed a significant reduction of 
hypoploid DNA after treatment with both pro-apoptotic inducers at 24 h post treatment 
(Figure 3.14D; p<0.05). At 48 h post treatment, we observed a significant decrease in the 
appearance of hypoploid DNA after staurosporine treatment (p<0.05) and a trend of TgBI-
3 to reduce brefeldin A-induced hypoploid DNA. 
Collectively, these results indicated an evolutionary conserved protective effect of 
Bax inhibitors of T. gondii to reduce cell death induction in mammals and suggested a role 
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Figure 3.14. Inhibition of hypoploid nuclei by TgBIs upon cell death stimulation in HeLa cells. TgBIs-
expressing HeLa cells (clones TgBI-1-22, TgBI-2-23 and TgBI-3-12) were treated with 0.3 µM staurosporine 
(stau) or 10 µM brefeldin A (breA) or were left untreated (control). A, Representative FACS histograms of 
TgBI-2-expressing HeLa cells are depicted. Numbers within the histogram are percentages of sub G0/G1 
cells of TgBI-2 in comparison to HeLa WT at 48 h after treatment with cell death inducers. B, C, D, Bars 
represent means ± S.E.M. (n = 3 for TgBI-1, n = 4 for TgBI-2 and TgBI-3) of sub G0/G1 nuclei of TgBI-1-, 
TgBI-2- and TgBI-3-expressing HeLa cells, respectively. Untreated controls are shown as open bars, cells 
treated with staurosporine are shown as filled bars and cells treated with brefeldin A are shown as hatched 
bars.  ** p < 0.01; * p < 0.05. 
 
3.3.3. Toxoplasma gondii Endonuclease G (TgEndoG) 
3.3.3.1. Bioinformatic analysis 
A candidate protein that might contribute to the execution of apoptosis-like cell 
death in T. gondii is Endonuclease G (TgEndoG). The corresponding gene was identified 
during our in silico analysis of the T. gondii genome database (see section 3.3.1; 
TgME49_008710). The predicted protein shows 31.5 %, 38.1 %, 36.1 % and 35.3 % 
identity with EndoG of Homo sapiens, Mus musculus, Bos taurus and S. cerevisiae, 
respectively. The putative TgEndoG consists of 894 amino acids and has a molecular 
weight of 96.2 kDa, much higher than the ~ 30 kDa of mammalian EndoG (van Loo et al., 
2001) or the ~ 60 kDa of Leishmania EndoG (Rico et al., 2009). The active site of 
A B 
C D 
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mammalian EndoG is characterised by a DRGH motif which is replaced by a SKGH motif 
in T. gondii (Figure 3.15, upper panel). Additionally, asparagine (N), an important residue 
for divalent ion binding to support function of EndoG, is conserved in TgEndoG. The 
structure of TgEndoG was predicted using PyMOL Molecular Graphic System. The results 
showed that the structure of TgEndoG is compatible with an active Endonuclease G 






Figure 3.15.   Alignment of EndoG sequences from different species and prediction of TgEndoG structure. A, 
TgEndoG consists of two non-specific endonuclease domains. The DRGH motif which is typical for EndoG 
of mammals and yeast and constitutes the active site domain, was replaced by SKGH in TgEndoG. B, 
Structure of TgEndoG was analysed using the PyMOL Molecular Graphics System, Version 1.3r1-edu-
Win32 Schrödinger, LLC (collaboration with Antonio Jiménez-Ruiz, Universidad de Alcalá, Madrid). The 
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3.3.3.2. T. gondii Endonuclease G had a non-mitochondrial localisation 
MitoProt analysis, a software tool to predict a mitochondrial targeting of a protein, 
showed that TgEndoG is likely transported into mitochondria. However, YFP-tagged 
endogenous T. gondii EndoG (collaboration with Martin Thiele and Wolfgang Bohne, 
Göttingen) revealed that this protein has a non-mitochondrial localisation. YFP-tagged 
TgEndoG was detected using anti-YFP primary antibodies and fluorochrome-conjugated 
secondary antibodies (Figure 3.16A). To stain mitochondria, MitoTracker
®
 Red CM-
H2XRos (Invitrogen) was used prior to labelling with anti-YFP antibodies (Figure 3.16B). 
These analyses also revealed that TgEndoG is constitutively expressed since it was already 
observed in single parasites and appeared not to be influenced by the size of the 
parasitophorous vacuole (Figure 3.16A). 
 
Figure 3.16.  YFP-tagging of endogenous TgEndoG demonstrated that TgEndoG has a non-mitochondrial 
localisation. Tagging of TgEndoG with YFP and the detection were performed in collaboration with Martin 
Thiele and Wolfgang Bohne, Georg-August University of Göttingen. Images are kindly provided by Martin 
Thiele. A, Expression of TgEndoG (red fluorescence) was detected in single parasites and the intensity of 
TgEndoG expression did not change with the growth of the parasitophorous vacuole. B, Co-staining with 
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3.3.3.3. Cloning and expression of T. gondii Endonuclease G 
To further analyse the function of TgEndoG, molecular cloning of TgEndoG was 
performed. To this end, we generated a construct plasmid which contained the full length 
sequence of TgEndoG and heterologously expressed the recombinant protein in E. coli. 
After purification of the recombinant TgEndoG protein, it can be used for downstream 
experiments. In our study, the EndoG coding sequence was released from a construct 
plasmid TgEndoG-pBluescript SK- (synthetically generated; purchased from 
ATG:biosynthetics GmBH) by digestion using EcoRI and KpnI and ligated into EcoRI- and 
KpnI-digested expression vector pASK-IBA3plus (Figure 3.17A). pASK-IBA3plus is an 
expression plasmid where expression of the recombinant protein is under transcriptional 
control of a tetracycline-regulated promoter. It also confers resistance against ampicillin. 
The protein will be a fusion with a Strep-tag at the C-terminus of the recombinant protein. 
Propagation of the plasmid was done in E. coli DH5α. Screening of positive clones were 
done by colony PCR and digestion using restriction enzymes. The correct sequences and 
orientation were further confirmed by DNA sequencing (see Chapter 2, section 
2.2.4.4.1.7). For expression purposes the recombinant plasmids were transformed into E. 
coli BL21 codon plus. This strain of E. coli is designed for overcoming codon usage bias 
because it contains extra copies of genes encoding rare tRNAs, which often restrict the 
translation of heterologous proteins in E. coli (Rosano and Ceccarelli, 2009). We optimised 
the expression methods by modifying the concentration of anhydrotetracycline, ranging 





C and room temperature) during induction of protein expression. 
However, despite these attempts to optimise protein expression we observed only a weak 
to moderate expression of TgEndoG using immunoblotting. The best condition for 
induction of expression of pASK-IBA3plus-TgEndoG in E. coli BL21 codon plus was 
observed using 25 ng/ml anhydrotetracycline at room temperature for 2 h (Figure 3.17B). 
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Figure 3.17. Recombinant plasmid construct of pASK-IBA3plus containing TgEndoG coding sequence and 
heterologous expression of the fusion protein as detected by immunoblotting. A, The construct of the 
recombinant plasmid pASK-IBA3plus containing the full length coding sequence of TgEndoG is indicated. 
B, The recombinant protein was expressed in E. coli BL21 codon plus using 25 ng/ml anhydrotetracycline at 
room temperature. TgEndoG was detected using anti-Strep-tag antibodies via immunoblotting and was 
visualised using a chemiluminescence imaging device (Luminescent Image Analyzer LAS-4000, Fujifilm). 
Representative immunoblots of negative control (contains only empty vector) and three positive clones are 
shown. 0, 0 h (non-induced); 1, 2, 3, hour (s) post induction.  
 
We also subcloned and expressed TgEndoG using other expression vectors, 
pRSET-A and pQE30. pRSET-A is an expression plasmid bearing an ampicillin resistant 
gene and which generates proteins fused with a 6xHis-tag at the N-terminus of the 
recombinant proteins. Expression of the recombinant protein is controlled by the strong 
bacteriophage T7 promoter. For expression of the gene of interest, sufficient T7 RNA 
polymerase that binds to the T7 promoter and transcribes the gene is needed; induction of 
the polymerase can be done using IPTG (Makrides, 1996). pQE30 also provides a 6xHis-
tag and carries an ampicillin resistant gene. Instead of the T7 promoter, pQE30 has a T5 
promoter, a native promoter. As T7, T5 is also an IPTG-inducible promoter (Makrides, 
1996). Propagation of the plasmids containing TgEndoG was also done in E. coli DH5α. 
Transformants were screened by colony PCR and digestion using appropriate restriction 
enzymes (see Chapter 2, section 2.2.4.4.1.7).  E. coli BL21 codon plus was again used for 
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expressing of the protein. We optimised concentrations of IPTG, ranging from 0.5 mM to 




C, or room temperature. However, we 
could again not express TgEndoG protein in an amount that would allow downstream 
purification approaches. The best protein expression in this case was after induction with 2 
mM IPTG at room temperature for 2 h (data not shown). 
 
3.4. Regulation of apoptosis-like cell death in T. gondii 
3.4.1. Disruption of mitochondrial membrane potential following treatment of 
extracellular parasites with pro-apoptotic stimuli 
The absence of bona fide caspases and Bcl-2 family members in the Toxoplasma 
genome (Nedelcu, 2009 and our own bioinformatic search) suggested a caspase-
independent apoptosis-like cell death mechanism in T. gondii. Mitochondria play a central 
role in such pathways by releasing pro-apoptotic factors e.g., cytochrome c, AIF and 
EndoG following cell death stimuli. Thus, mitochondrial membrane potential (ΔΨm) is 
often considered an indicator of cellular health. MitoTracker staining and confocal 
microscopy was applied to determine ΔΨm in T. gondii upon cell death induction.  
To this end, extracellular parasites were incubated with staurosporine or miltefosine 
or were mock-treated for 24 and 48 h. Freshly isolated as well as mock-treated parasites 
were used as controls. At the indicated time points, parasites were stained with 
MitoTracker® Orange CM-H2TMRos and analysed using confocal laser scanning 
microscopy. The number of parasites with an intact ΔΨm was determined from at least 500 
cells. Our result revealed that freshly isolated parasites accumulated the MitoTracker probe 
indicating an intact ΔΨm. Miltefosine-treated parasites showed a prominent disruption of 
the ΔΨm. The majority of parasites (more than 80 %) significantly lost their ΔΨm already 
at 24 h post treatment (Figure 3.18; p<0.01) and this decreased further until 48 h of 
treatment. In contrast, staurosporine treatment had no significant effect on the 
mitochondrial membrane potential as compared to mock-treated parasites (Figure 3.18). 
Thus, different cell death pathways appear to exist in T. gondii, one of which involves loss 
of ΔΨm after miltefosine treatment. 
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Figure 3.18. Dissipation of mitochondrial membrane potential (ΔΨm) after treatment of extracellular 
parasites with pro-apoptotic stimuli. Extracellular parasites were treated with 10 µM staurosporine (stau) or 
20 µM miltefosine (HePC) or were mock-treated for 24 and 48 h. At the indicated time points, parasites were 
stained with MitoTracker® Orange CM-H2TMRos A, Differential interference contrast (DIC) and 
fluorescence images were recorded by confocal laser scanning microscopy. Images are representative of 
extracellular parasites stained with MitoTracker (red labelling) at 48 h post treatment with pro-apoptotic 
stimuli. B, The graph shows the percentage of parasites with intact ΔΨm at 24 and 48 h after pro-apoptotic 
treatment as determined from at least 500 cells per sample. Data represents means ± S.E.M. from three 
independent experiments. ** p < 0.01.  
 
3.4.2. Activation of caspase-like proteases was detected in T. gondii after treatment 
with pro-apoptotic stimuli 
Although protozoa do not express genuine caspases, i.e. crucial proteins for 
execution of apoptosis in mammals, caspase-like activities have been identified during 
PCD in several unicellular eukaryotes. Moreover, some proteases have been identified in 
the T. gondii genome and their expression was up-regulated upon cell death induction (see 
section 3.3.1). To test the possibility that caspase-like protease might be activated during 
cell death in T. gondii, CaspaTag assay and subsequent flow cytometry to identify 
activation of caspase-like proteases within cells was performed. To this end, extracellular 
parasites were cultivated in the presence of staurosporine and miltefosine and examined at 
various time points after treatment.  
In situ labelling of parasites with a caspase inhibitor and flow cytometry revealed a 
strong and significant increase of caspase labelling within 2 h of miltefosine treatment 
A 
B 
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(Figure 3.19;  p<0.01). The caspase activity remained high at 4 h (p<0.05) after miltefosine 
treatment before it declined to control levels until 48 h post treatment. Following 
staurosporine treatment, a significant increase in caspase labelling within 2 h of treatment 
as compared to mock-treated controls (p<0.01) was also observed. However, activation of 
caspase-like proteins was much lower than after miltefosine treatment and reached control 
levels already at 4 hours of treatment. Mock-treated control parasites did not show any 
significant increase in the caspase-like activity (Figure 3.19). 
 
 
Figure 3.19.  Caspase-like proteases were activated in T. gondii following pro-apoptotic treatment. Parasites 
were freshly isolated or were treated with 10 μM staurosporine (stau), 20 μM miltefosine (HePC), or were 
mock-treated for 2, 4, 24 and 48 h. Parasites were stained with a fluorescein-conjugated broad spectrum 
caspase inhibitor (CaspaTag) and analysed by flow cytometry. A, FACS histograms represent freshly isolated 
parasites or those treated with pro-apoptotic stimuli for 2 h (open histograms) as compared to mock-treated 
parasites (filled histograms). B, The graph shows the percentage of CaspaTag-positive parasites at different 
time points (2 to 48 h) post treatment as revealed by flow cytometry. Data represents means ± S.E.M. from 
three independent experiments. ** p < 0.01; * p < 0.05.  
 
3.4.3. Protease inhibitors prevented  miltefosine-triggered cell death in extracellular 
parasites 
To further confirm an involvement of proteases in the regulation of apoptosis-like 
cell death in T. gondii, parasites were pre-treated with the cysteine protease inhibitor E64 
or the pan-caspase inhibitor Z-VAD-FMK from 1 h prior to the induction of cell death with 
staurosporine or miltefosine onwards. The appearance of DNA fragmentation was then 
visualised using TUNEL assay and confocal laser scanning microscopy. 
Emergence of DNA strand breaks as detected by TUNEL assay could be observed 
in 8.10 % of untreated extracellular parasites. As expected from our previous results, 
A B 
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treatments with staurosporine and miltefosine in the absence of both protease inhibitors 
significantly increased the number of TUNEL-positive parasites to 25.18 % and 36.16 %, 
respectively (Figure 3.20; p<0.05). Protease inhibitors E64 and Z-VAD-FMK revealed a 
strong inhibition of the appearance of DNA strand breaks in parasites treated with 
miltefosine; the number of TUNEL-positive parasites significantly decreased to 
approximately 12 % (p<0.05). In contrast, both protease inhibitors did not significantly 
inhibit staurosporine-induced DNA strand breaks although we observed a trend of E64 to 
partially diminish DNA fragmentation following staurosporine treatment (Figure 3.20). 
 
Figure 3.20. DNA strand breaks in T. gondii after treatment with miltefosine was inhibited by the presence of 
protease inhibitors. Parasites were treated with 100 µM of protease inhibitors E64 or Z-VAD-FMK for 1 h 
prior to the induction of cell death with 10 µM staurosporine (stau) or 20 µM miltefosine (HePC). After 48 h, 
DNA strand breaks were visualised by TUNEL staining. Number of TUNEL-positive parasites was counted 
from 500-800 cells per sample. Bars represent means ± S.E.M. from three independent experiments. * p 
<0.05. 
 
Together, these results suggested the existence of different cell death pathways in T. 
gondii one of which involves loss of ΔΨm and caspase-like proteases and which is 
specifically activated by miltefosine. 
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4.1. Cell death markers identified in T. gondii are characteristic for apoptosis in 
metazoans 
The concept that unicellular organisms undergo a form of programmed cell death 
which resembles apoptosis as described in metazoa is still a matter of debate. However, 
there are increasing numbers of reports describing the existence of an apoptosis-like cell 
death in single-celled organisms. The existence of apoptosis-like cell death in protozoan 
parasites indicated that parasites in a distinct host might organise themselves in populations 
and that communication might occur intercellularly between individuals (Duszenko et al., 
2006; James and Green, 2004). Single-celled organisms could benefit from a self-killing 
mechanism in order to ensure the survival of a part of the population (Ameisen, 2002).  
Apoptosis in multicellular organisms is characterised by specific morphological 
changes of a cell which include blebbing, condensation of the cell nucleus, degradation of 
nuclear DNA, and cell shrinkage (Kroemer et al., 2009). Apoptotic cells also exhibit  
several biochemical features such as internucleosomal cleavage of DNA, exposure of PS 
on the outer leaflet of the plasma membrane, and proteolytic cleavage of intracellular 
substrates (Elmore, 2007). Apoptotic cells are quickly removed by phagocytes before they 
can release their intracellular contents into the extracellular environment. Consequently, an 
inflammatory response will not be induced (Zimmermann et al., 2001).  
Morphological and biochemical changes, e.g. cell shrinkage, phosphatidylserine 
exposure, DNA degradation, dissipation of the mitochondrial membrane potential (ΔΨm), 
or caspase-like activity have been identified following treatment with different pro-
apoptotic stimuli in protozoan parasites including Leishmania, Trypanosoma, Plasmodium, 
Trichomonas, Blastocystis, Entamoeba, or Giardia (reviewed in Jiménez-Ruiz et al., 
2010).  
Here, we demonstrated that extracellular T. gondii shares several markers of 
apoptosis following treatment with common stimuli which are known to induce apoptosis 
in multicellular organisms. DNA fragmentation, a hallmark of apoptosis, was induced in T. 
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gondii following staurosporine, miltefosine, H2O2, and camptothecin treatment. During 




-dependent endonucleases (Elmore, 
2007) into DNA fragments with a 5‘-phosphate and 3‘-hydroxyl group (Nagata et al., 
2003). Terminal deoxynucleotidyl transferase-mediated X-dUTP nick end labelling 
(TUNEL) assay was developed and has been widely used to label the cleaved DNA. We 
observed that the highest numbers of TUNEL-positive parasites were induced using 
staurosporine (a potent protein kinase inhibitor) and miltefosine (an antileishmanial agent). 
 Upon treatment with both stimuli, decreases in cell volume and rounding-up of the 
parasites have also been identified. Cell shrinkage is a regulated and rapid process during 









 channel (McCarthy and 
Cotter, 1997). Furthermore, rounding-up of cells ensues when cytoskeleton proteins are 
cleaved by activated proteases (Taylor et al., 2008). 
Phosphatidylserine (PS) loses its asymmetric distribution in the lipid bilayer of the 
plasma membrane and is translocated from the inner to the outer leaflet of the plasma 
membrane during initiation of apoptosis (Jiménez-Ruiz et al., 2010). Two potential 
mechanisms have been suggested to explain this process. First, exposed PS occurs by the 
activation of a scramblase, an enzyme that is capable to randomise PS distribution across 
the plasma membrane. Second, exposure of PS is mediated by trafficking of lysosomes to 
the cell surface, a process that is mediated by calcium (Lee et al., 2013). Externalisation of 
PS acts as an ―eat me‖ signal for surrounding cells (Kroemer et al., 2009). Binding of 
Annexin V to exposed PS has become an important tool for the evaluation of apoptosis. 
Here, we observed that in extracellular T. gondii, the percentage of Annexin V-positive 
cells significantly increased after treatment with staurosporine and miltefosine. 
Remarkably, the integrity of the plasma membrane (as detected using 7-AAD staining) was 
maintained, indicating apoptosis instead of necrosis.  
Our results are consistent with a previous study which described that tachyzoites of 
T. gondii exhibited markers of apoptosis, e.g. chromatin condensation, DNA degradation 
and hypoploid nuclei after treatment with the exogenous nitric oxide (NO) donor, sodium 
nitroprusside (Peng et al., 2003). It has been also shown that parasites exposed their PS to 
inhibit NO production (which contributes to the control of T. gondii growth) to ensure its 
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persistence in activated macrophages (Seabra et al., 2004) or to facilitate parasite and host 
survival (Santos et al., 2011).  
Importantly, intracellular T. gondii also showed DNA strand breaks following 
treatment with staurosporine, but not miltefosine, at 3 and 6 h post treatment. The absence 
of DNA fragmentation during early time points of miltefosine treatment does not rule out 
an effect of this drug on intracellular parasites. It was described that the parasiticidal effect 
of miltefosine on intracellular Neospora caninum was only observed after 20 h of 
treatment (Debache and Hemphill, 2012); thus, the effect of miltefosine on intracellular T. 
gondii for longer time periods (or with higher concentration of miltefosine) awaits 
clarification.  
Staurosporine and miltefosine have also been used to induce apoptosis in 
multicellular organisms. For instance, staurosporine induced apoptosis in L1210/0 and 
L1210/S cells (a carcinogen-induced acute lymphoid leukemia from DBA mice) via 
caspase-dependent and caspase-independent pathways (Belmokhtar et al., 2001). 
Miltefosine induced apoptosis in a variety of tumour cell lines and Leishmania spp., 
possibly via perturbation of fatty acid and sterol metabolism, mitochondrial dysfunction 
and/or inhibition of the Akt/PKB pathway (Dorlo et al., 2012) 
Collectively, our data strongly indicated that following treatment with pro-apoptotic 
stimuli, T. gondii can undergo a form of programmed cell death that shows characteristic 
features of apoptosis as observed in metazoa.  
 
4.2. Possible benefits of an apoptosis-like cell death in T. gondii 
Apoptosis in metazoa is an essential mechanism to remove cells without inducing 
an inflammatory response. It fulfills crucial functions in a wide range of physiological 
processes, for instance during embryonic development, to maintain tissue homeostasis, to 
eliminate damaged or unwanted cells, or as a defence mechanism against infection 
(Ameisen, 2002; Proto et al., 2013). If an apoptosis-like cell death in protists does exist, a 
major question that arises is what the advantages for protozoan parasites to commit suicide 
are. This question is critical since a cell death programme would only evolve if it is 
beneficial for the survival of the parasites. 
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An apoptosis-like cell death arguably plays essential roles in regulating parasites 
densities in distinct host compartments and in avoiding inflammatory responses to ensure a 
perpetuation of infection (van Zandbergen et al., 2010). For instance, Trypanosoma cruzi 
undergoes apoptosis in order to control cell proliferation and ensure the survival of the 
parasite population as a whole (Ameisen et al., 1995).  Another example has been 
described in a malaria parasite, Plasmodium berghei; the parasite dies naturally by 
apoptosis in the mosquito midgut before invading the intestinal epithelium to limit 
intensity of infection (Al-Olayan et al., 2002).   
In our study, we elucidated at what time T. gondii, during its natural life cycle, 
undergoes an apoptosis-like cell death. We found that DNA fragmentation, as detected by 
TUNEL staining, was not prevalent during the acute stage of infection in the 
intraperitoneal cavity of T. gondii-infected mice. However, we identified TUNEL-positive 
bradyzoites of T. gondii within tissue cysts from isolated brains of chronically infected 
mice. Thus, the results suggested that an apoptosis-like cell death in T. gondii did not 
contribute during acute infection, but may play a role during chronic infection. Our results 
were not in line with a previous study that described a T. gondii parasite population 
exposing PS on the outer leaflet of the plasma membrane in the peritoneal fluid of mice 
during acute infection (Seabra et al., 2004). However, since DNA fragmentation occurs in 
the later phase of apoptosis (Elmore, 2007), the absence of TUNEL-positive parasites in 
the peritoneal cavity of infected mice, as we detected it here, did not completely rule out 
the potential that cells were in the early stage of apoptosis.  
Purposes of an apoptosis-like cell death in T. gondii, whether altruistic or 
otherwise, are still an issue to be elucidated. Altruistic suicide with respect to nutrient 
supply (James and Green, 2004) is unlikely for bradyzoites of T. gondii because this stage 
grows slowly and the metabolism is strongly reduced as compared to the tachyzoite stage. 
Moreover, we need to note that T. gondii is an obligate intracellular pathogen. One 
problem that is commonly faced by an intracellular organism is how to ensure sufficient 
space for replication (Patricia Leiriao, 2004). Therefore, one possible advantage of an 
apoptosis-like cell death in bradyzoites apparently is limiting the population size within 
tissue cysts and consequently avoiding damage of the host cell and thus ensuring the 
survival of the viable bradyzoites. Death of the host cells might lead to death of 
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bradyzoites since intact host cells provides a continuous supply of nutrient (Pavesio et al., 
1992). On the other hand, rupture of tissue cysts is occasionally observed and is 
accompanied with an inflammatory response of the host (Dubey et al., 1998). A 
subpopulation of bradyzoites with apoptotic features might also limit the immune response 
of the host and thereby facilitating the viable bradyzoites to develop into new cysts. As 
described in Leishmania major, the presence of apoptotic parasites can silence 
polymorphonuclear (PMN) cell functions by releasing the anti-inflammatory cytokines 
TGF-ß and IL-10 thereby enabling viable parasites to develop a productive infection (van 
Zandbergen et al., 2006). 
Importantly, toxoplasms in a distinct host are a clonal population since they 
regularly originate from a single inoculum transferred by ingestion of undercooked meat 
from a chronically infected live stock (containing bradyzoites within tissue cysts) (Tenter 
et al., 2000). Furthermore, acute T. gondii infection provokes a strong Th1-type immunity 
that restricts dissemination of parasites and allows the survival of the host but which also 
mostly prevents a productive super-infection with a second T. gondii strain. Consequently, 
bradyzoites are formed, predominantly in the muscle and brain tissues (Filisetti and 
Candolfi, 2004). Thus, if we consider T. gondii as a population of genetically identical 
organisms within its host, a form of programmed cell death of a subpopulation of parasites 
may be evolutionary sustainable because it could help avoiding an overwhelming parasite 
load and host death before parasite transmission would have been possible (Luder et al., 
2010). This may be particularly important for the T. gondii transmission cycle which 
critically depends on establishing a long-lasting chronic infection.  
Taken together, our findings exhibited that an apoptosis-like cell death might play 
roles during chronic infection of T. gondii. Possibly, it is responsible for the regulation of 
bradyzoite density within tissue cysts or to avoid overwhelming immune responses of the 
host when bradyzoites are released as a result of tissue cyst rupture. 
 
4.3. Identification of putative regulators of an apoptosis-like cell death in T. gondii 
Caspases and Bcl-2 family proteins play essential roles in the regulation and 
execution of apoptosis in multicellular organisms. Since T. gondii does not express bona 
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fide caspases or members of Bcl-2 proteins, an apoptosis like cell death in T. gondii is 
assumed to occur in a caspase-independent fashion. 
We identified 17 genes via an in silico analysis of the Toxoplasma genome database 
with annotated functions in programmed cell death and which were differentially 
expressed following pro-apoptotic treatment of the parasite. Virtually all mRNAs of the 
seventeen selected genes increased in a time-dependent fashion following staurosporine 
treatment of T. gondii. We observed an up-regulation of the mRNAs by more than 10-fold 
for PDCD2 (TgME49_105490), a putative ELMO (TgME49_053000), a DNA/RNA 
endonuclease (TgME49_008710), a putative Fas apoptotic inhibitory molecule 
(TgME49_049770) and two calpain-like proteins. A strong up-regulation of the transcript 
of PDCD2 was also observed after treatment with miltefosine while other transcripts were 
only slightly up-regulated, or even not at all in response to miltefosine.   
Increased PDCD2 expression can induce apoptosis in human cells, at least in part 
by activating a caspase cascade, whereas repression of PDCD2 is involved in the 
pathogenesis of certain human lymphomas (Baron et al., 2002; Baron et al., 2010). It is 
evolutionarily conserved and has been identified in all eukaryotes (Nedelcu, 2009). The 
ELMO protein plays roles in the engulfment and elimination of apoptotic cells in 
mammals, a final step of the apoptosis process (Gumienny et al., 2001). Calpains, as 
caspases, are cysteine proteases but compared to caspases, calpains show a broad spectrum 
with respect to cleavage specificity. Calpains, in mammalian cells, cleave a large number 
of proteins during apoptosis; calpains act together with caspases or might also cleave 
proteins independently of caspases or in combination with other proteins such as AIF 
(apoptosis inducing factor) (Vandenabeele et al., 2005). The DNA/RNA endonuclease (in 
our study named TgEndoG) and putative Fas apoptotic inhibitory molecules (in our study 
named TgBIs) are of our interest considering that both of these proteins are known to play 
critical roles in caspase-independent apoptosis pathways (described in more detail below).  
Bax inhibitor-1 (BI-1) was initially described as testis enhanced gene transcript 
(TEGT), and has been cloned from adult rat testis. The predicted sequence of human BI-1 
revealed a 90 % identity to TEGT (Watanabe and Lam, 2009). It contains 6 to 7 
transmembrane domains and is capable to inhibit cell death in animal and plant cells 
(Huckelhoven, 2004). The protein is mainly localised to ER membranes, but can also be 
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detected at mitochondria (Chae et al., 2004; Xu and Reed, 1998). BI-1 does not directly 
interact with Bax (a pro-apoptotic protein of the Bcl-2 family), but exerts its anti-apoptotic 
function by an interaction with anti-apoptotic members of the Bcl-2 protein family, i.e. 
Bcl-2 and Bcl-XL (Watanabe and Lam, 2009; Xu and Reed, 1998). This view is supported 
by the fact that plants have BI-1 even though Bax cannot be identified in plant genomes 
(Huckelhoven, 2004). There are no well-characterised motifs for post-translational 
modification of BI-1, however the C-terminus of the protein contains a lysine-rich motif 
(EKDKKKEKK) that resembles the pH-sensing motif of ion channels (Kim et al., 2008; 
Watanabe and Lam, 2009).  
The T. gondii genome revealed the presence of three putative Bax-inhibitors and 
they were named TgBI-1, TgBI-2 and TgBI-3, respectively. Analysis of TgBIs sequences 
exhibited no particular motif that could be used to predict their function. After 
heterologous expression in HeLa cells, immunofluorescence assays using anti-FLAG 
antibody recognising the FLAG tag fusion proteins of TgBIs showed that TgBI-1 has a 
perinuclear localisation, TgBI-2 has a predominantly cell surface expression and TgBI-3 
has both a perinuclear and a cell surface localisation. It is not surprising that these three 
proteins have different localisations, since Bax-inhibitors in higher eukaryotes reside in 
different locations (Chae et al., 2004; Xu and Reed, 1998). However, our results showed 
evolutionary conserved protective effects of the BI proteins from T. gondii to mammals. 
Heterologous expression of TgBIs in a well-described mammalian apoptosis system, 
namely HeLa cells, showed an inhibition of caspase activity by TgBI-1 and TgBI-2, but 
not TgBI-3, following treatment with staurosporine (a potent protein kinase inhibitor) and 
brefeldin A (an inhibitor of protein transport from the ER to the Golgi apparatus), 
suggesting that TgBIs impact downstream cell death pathways which involve caspases. 
Moreover, TgBIs in HeLa cells partially prevented the appearance of hypoploid DNA after 
treatment of TgBIs-transfected HeLa cells with staurosporine and brefeldin A. A decrease 
of the DNA content caused by apoptosis, so-called hypoploid DNA (Krysko et al., 2008) is 
a common feature of apoptosis that can be also identified as a consequence of caspase-
independent pathways of apoptosis (Jones et al., 1999). Although the role of TgBIs in the 
regulation of apoptosis in T. gondii remains elusive, it is possibly crucial in the regulation 
of ER-associated apoptotic cell death. It has been described that accumulation of unfolded 
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proteins in the lumen of the ER (ER stress) induced by oxidative stress, Ca
2+
 homeostasis 
disruption or hypoxia triggers an apoptotic cell death in mammals (Xu et al., 2005). Stress 
in the ER induces a mitochondrial-dependent apoptosis pathway or activation of caspase 
12 which consequently activates the caspase cascade, leading to cell death (Breckenridge 
et al., 2003; Xu et al., 2005). In mammalian cells, BI-1 suppressed the ER stress response 
under mild ER stress conditions, indicating that BI-1 function is necessary during the early 
stage of  ER stress adaptation to prevent activation of apoptosis (Lisbona et al., 2009). 
Moreover, BI-1 also plays a role in regulating Ca
2+
 homeostasis in the ER (Robinson et al., 
2011).  
Another protein that is involved in a caspase-independent apoptosis pathway in 
mammals is EndoG. Endonuclease G was initially defined as an endonuclease that 
specifically cleaves guanine (G) tracts in DNA extracts of chicken erythrocytes even 
though later it was recognised that the protein is also able to induce DNA nicks within 
cytosine tracts (Low, 2003). The protein belongs to a large family of DNA/RNA non-
specific nucleases. Nucleases of this family are expressed in many prokaryotes and 
eukaryotes including bacteria, protozoa, fungi, slime moulds, invertebrates and vertebrates 
(Schafer et al., 2004). The active site is characterised by a DGRH motif that contains a 
critical histidine residue and is structurally part of the ßßα-Me-finger motif. EndoG 
requires Mg
2+
 or other divalent cations for its activity (Rico et al., 2009; Schafer et al., 
2004). Genes encoding EndoG have also been identified in Leishmania infantum (Rico et 
al., 2009) and Trypanosoma (Gannavaram et al., 2008) and share ~30 % identity with 
human EndoG. The predicted nuclease domains of Leishmania and Trypanosoma EndoG 
displayed 48 % identity to human EndoG, in which aspartic acid at the DRGH motif of 
mammalian EndoG is replaced by serine (DRGH is substituted by a SRGH motif). In 
mammalian cells, EndoG is translocated from mitochondria to the nucleus following 
treatment with apoptotic stimuli, leading to oligonucleosomal DNA fragmentation 
independently of caspases (Arnoult et al., 2003; Schafer et al., 2004). Putative EndoG of 
Leishmania and Trypanosoma also showed pro-apoptotic nuclease activity; the protein, 
following cell death induction, was released from mitochondria and translocated into the 
nucleus consequently leading to cell death (Gannavaram et al., 2008; Rico et al., 2009). 
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The predicted T. gondii EndoG (TgEndoG) amino acid sequence shared 31.5 % 
identity with human EndoG.  Prediction of the TgEndoG structure using PyMOL showed 
that TgEndoG structurally resembles those of Endonuclease G from other species. The 
DRGH motif in the active site of human EndoG or the SRGH motif in the active site of 
EndoG from Leishmania and Trypanosome is replaced by a SKGH motif in TgEndoG. 
Importantly, however, the histidine and asparagine residues which are important for 
catalytic activities and divalent ion binding respectively, are conserved between TgEndoG 
and that from Leishmania and Trypanosoma (Gannavaram et al., 2008). Interestingly, 
EndoG in other species is known to reside in mitochondria, but TgEndoG has a non-
mitochondrial localisation as detected by tagging of endogenous TgEndoG and 
MitoTracker co-staining; the protein showed a vesicular morphology and was dispersed 
within the parasite cytosol. We have successfully cloned the gene encoding TgEndoG but 
we still need to optimise the expression method to obtain an adequate amount for 
purification and downstream experiments. Precise localisation and purification of 
TgEndoG is also critical to be addressed in order to further elucidate whether the TgEndoG 
might have functions in an apoptosis-like cell death mechanism in T. gondii. This view is 
supported by the facts (i) that EndoG showed pro-apoptotic nuclease activity in other 
protozoan parasites, (ii) that the predicted structure of TgEndoG showed a conservation to 
the active domain of EndoG (histidine and asparagine residues) in metazoans, and (iii) that 
we detected DNA fragmentation in T. gondii following treatment with pro-apoptotic 
stimuli in the absence of caspases, suggesting that EndoG might be involved. 
Together, we have identified 17 cell death-associated genes via in silico analysis 
from the Toxoplasma genomic database, which were differentially expressed following 
pro-apoptotic treatment of the parasite. TgBIs and TgEndoG are of interest. Our findings 
on TgBIs indicated evolutionary conserved protective effects of BI proteins from T. gondii 
to mammals and suggested a role of TgBI proteins in the regulation of apoptosis-like cell 
death in T.gondii. 
 
4.4. The existence of distinct pathways of an apoptosis-like cell death in T. gondii  
 Although similarities clearly exist between protozoa and higher eukaryotes in some 
features of apoptosis and apoptosis-related molecules, molecular pathways of apoptosis-
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like cell death in protozoan parasites have not yet been convincingly identified. However, 
it is quite obvious that the mechanism of apoptosis in parasites and higher eukaryotes 
differs (Debrabant and Nakhasi, 2003).  
In our study, we found clear evidence that distinct apoptosis-like cell death 
pathways were induced in T. gondii in response to staurosporine and miltefosine 
treatments, respectively. Following treatment of extracellular parasites with miltefosine, a 
prominent loss of the mitochondrial membrane potential (ΔΨm) was detected. Conversely, 
staurosporine treatment had no significant effect on ΔΨm.   
Mitochondria in vertebrates are crucial in regulating cell death through different 
mechanisms, e.g. via transducing upstream apoptotic signals into the caspase cascade or by 
releasing caspase-independent pro-apoptotic molecules such as EndoG and AIF (Wang and 
Youle, 2009). Collapse of the mitochondrial membrane potential was considered a point of 
no return in the apoptosis pathway (Jeong and Seol, 2008). Disruption of the mitochondrial 
membrane potential has been associated with apoptosis-like cell death in other organisms, 
such as Leishmania and Trypanosoma (Arnoult et al., 2002; Figarella et al., 2005) and 
Dictyostelium discoideum (Arnoult et al., 2001).  
T. gondii possesses a single mitochondrion; it is located in the anterior part of the 
protozoan body, is projected to the posterior region, and is considered to be crucial during 
the invasion process by the parasite (Melo et al., 2000). Here, we found that the 
mitochondrion of T. gondii is involved in a form of programmed cell death in the parasite 
especially after miltefosine treatment. However, importantly, it should be pointed out that 
the intact ΔΨm as observed after staurosporine treatment does not exclude an involvement 
of mitochondria in staurosporine-triggered apoptosis-like cell death in T. gondii since loss 
of ΔΨm is also not necessarily crucial for MOMP in mammals (Kroemer et al., 2007) and 
for execution of apoptosis in invertebrates (Wang and Youle, 2009; Zimmermann et al., 
2002). In addition, involvement of ΔΨm in Plasmodium apoptotic pathways is also a 
matter of debate (Jiménez-Ruiz et al., 2010) . 
Cysteine proteases appeared crucial during cell death induction of T. gondii by 
miltefosine. Here, we found a strong increase of CaspaTag-positive parasites within two 
hours of miltefosine treatment. CaspaTag used in our study is a non-cytotoxic fluorescent 
caspase inhibitor (FAM-VAD-FMK) that binds covalently to active caspases in living 
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cells. It should be noticed that VAD-FMK inhibits a broad spectrum of caspases; this 
implies that VAD-FMK does not only bind to genuine caspases. As described in 
Leishmania parasites, Z-VAD-FMK could bind to the cathepsin B-like protein (clan CA 
cysteine protease), explaining the detection of caspase binding in organisms which do not 
have genes encoding caspases (El-Fadili et al., 2010). Additionaly, VAD-FMK can also 
bind to legumain (clan CD cysteine protease) (Rozman-Pungercar et al., 2003). Thus, this 
may explain the efficient binding of VAD-FMK in T. gondii treated with miltefosine 
although a bona fide caspase in the T. gondii genome could not be identified (Nedelcu, 
2009 and our own bioinformatics analysis). Five genes encoding papain family cathepsins 
from T. gondii, including three cathepsin Cs (TgCPC1, 2, 3), one cathepsin B (TgCPB) and 
one cathepsin L (TgCPL), have been characterised in T. gondii (Que et al., 2007). These 
proteins have been described to play important roles in maturation of excretory/secretory 
proteins, in the invasion process and in parasite replication (Parussini et al., 2010; Que et 
al., 2007; Que et al., 2002); whether they have a role in T. gondii PCD has not yet been 
reported. Moreover, the crucial role of cysteine proteases in the regulation of an apoptosis-
like cell death in T. gondii following miltefosine treatment is supported by our findings 
that a cysteine protease inhibitor (E64) or a pan-caspase inhibitor (Z-VAD-FMK) strongly 
decreased the appearance of TUNEL-positive parasites after treatment of extracellular 
parasites with miltefosine. Treatment of parasites with staurosporine also induced a strong 
increase of caspase-like activity within two hours of treatment. However, in contrast, both 
protease inhibitors did not significantly inhibit staurosporine –induced DNA fragmentation 
although we observed a trend of E64 to partially diminish DNA strand breaks following 
staurosporine treatment. 
Our results indicated that different signalling pathways were activated in T. gondii 
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Table 4.1. Regulation of an apoptosis-like cell death in T. gondii following staurosporine 
and miltefosine treatment 
 Staurosporine Miltefosine 
Mitochondria Intact ΔΨm Loss of ΔΨm 
   
Caspase-like activity Small but significant  
increase at 2 hours 
Strong increase at 2 and 4 
hours 
   
Protease inhibitors (E64, 
zVAD) 
No significant impact Prevention of cell death 
   
Up-regulation of mRNAs 
(>10-fold) 
PDCD2, ELMO, DNA/RNA 




   
Downstream apoptotic 
markers 
DNA strand breaks 
(TUNEL), PS exposure,  
no membrane 
permeabilization, pyknosis, 
rounding-up of cell 
DNA strand breaks 
(TUNEL), PS exposure,  
no membrane 
permeabilization, pyknosis, 
rounding-up of cell 
 
  
4.5.  T. gondii underwent apoptosis-like cell death during drug treatment 
Here we identified for the first time that extracellular parasites underwent a form of 
cell death with the features of apoptosis, i.e. DNA fragmentation, during treatment with 
common drugs used to treat toxoplasmosis. DNA strand breaks, as detected by TUNEL 
assay, were most prominently and significantly induced in extracellular tachyzoites of T. 
gondii during atovaquone treatment. Atovaquone (hydroxynaphthoquinone) is an analogue 
of the inner mitochondrial coenzyme ubiquinone (coenzymeQ), which is an integral 
component of the mitochondrial electron transport chain. Atovaquone inhibits binding of 
ubiquinone to cytochrome bc1 (complex III) and consequently leads to collapse of the 
mitochondrial membrane potential (Baggish and Hill, 2002; McFadden et al., 2000). 
However, atovaquone induced only very low levels of DNA strand breaks in intracellular 
parasites as shown herein. DNA strand breaks in intracellular parasites, intriguingly, were 
significantly induced by clindamycin (a lincosamide) during the second cycle of infection.  
This was accompanied with a significant reduction of the number of parasites per 
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parasitophorous vacuole. It has been reported that clindamycin has a remarkable delayed 
lethal effect on T. gondii in vitro (Fichera et al., 1995; Pfefferkorn et al., 1992). Inhibition 
of T. gondii growth by clindamycin via an irreversible toxic effect on the host cell was 
excluded previously (Pfefferkorn et al., 1992), largely excluding the possibility that 
induction of DNA strand breaks in T. gondii occurred by an indirect mechanism mediated 
by the host cell. In T. gondii, clindamycin targets the apicoplast (a chloroplast-like 
organelle) protein translation by binding to the apicoplast large-subunit rRNA (Camps et 
al., 2002). However, it should be noted that only a minor percentage of parasitophorous 
vacuole contained TUNEL-positive intracellular parasites after treatment of intracellular 
parasites with clindamycin. This may be due to the fact that parasites are mainly sensitive 
to clindamycin during the very late stages of endodyogeny (Camps et al., 2002). 
 Together, these results demonstrated that an apoptosis-like cell death phenotype 
could be induced in extracellular and intracellular T. gondii following treatment with 
commonly used chemotherapeutic drugs against toxoplasmosis. 
 
Finally, our findings support a concept that unicellular organisms can undergo a 
form of programmed cell death, e.g. apoptosis. Herein we apply a combination of several 
techniques in order to unravel the existence of an apoptosis-like cell death in T. gondii. We 
proof that characteristic features of apoptosis, including DNA strand breaks, decrease in 
cell volume and externalization of PS can be identified in T. gondii. We also provide 
evidence that an apoptosis-like cell death mechanism in T. gondii might play a role during 
chronic infection. Importantly, treatment of intracellular parasites with clindamycin also 
induced an apoptosis-like cell death phenotype in a minor proportion of parasites. Using in 
silico analysis of the Toxoplasma genome resource, we identified 17 genes with annotated 
functions in programmed cell death and which were differentially expressed following pro-
apoptotic treatment of the parasite. Our focus on TgBIs indicated evolutionary conserved 
protective effects of BI proteins from T. gondii to mammals and suggested a role of TgBI 
proteins in the regulation of apoptosis. Furthermore, our data indicated that T. gondii 
developed distinct apoptosis-like cell death mechanisms in response to different pro-
apoptotic stimuli. One involves loss of the ΔΨm and activation of caspase-like proteases, 
which was specifically triggered by miltefosine. Further experiments to unravel the precise 
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mechanisms of apoptosis-like cell death in Toxoplasma are required. If an apoptosis-like 
cell death does exist in protozoan parasites, exploiting the process would give promising 
insights into the evolution of death pathways and may reveal novel strategies to combat 
infectious diseases of high impact on human and animal health.  
Summary 
 




 Toxoplasma gondii is an apicomplexan protozoan parasite which leads to widespread 
infections in humans and animals worldwide. The mechanisms of how T. gondii dies are 
largely unknown but knowledge of putative regulated cell death pathways are of major 
scientific interest and may lead to the development of novel antiparasitic therapies. 
Apoptosis, i.e. a form of programmed cell death (PCD), is a common feature of 
multicellular organisms but there is increasing evidence of apoptosis-like cell death 
pathways in unicellular organisms, including protozoan parasites. Aims of this study were 
to characterise PCD phenotypes in T. gondii, to unravel possible roles of PCD in T. gondii, 
to identify molecules that are responsible for PCD in T. gondii, and to characterise the 
regulation of cell death in T. gondii.  
 Terminal deoxynucleotidyl transferase-mediated X-dUTP nick end labelling 
(TUNEL) assays followed by flow cytometry were used to determine DNA strand breaks 
after treatment of the parasite with pro-apoptotic inducers. Basal levels of DNA strand 
breaks were detected in freshly isolated and untreated parasites. However, staurosporine 
and miltefosine significantly increased the number of TUNEL-positive extracellular 
parasites in a time-dependent manner from 24 to 72 hours post treatment. Staurosporine- 
and miltefosine-treated parasites also showed a reduction in cell size and a rounding-up 
morphology as compared to untreated parasites which is also indicative for an apoptosis-
like cell death. Furthermore, treatment with staurosporine and miltefosine led to a higher 
percentage of Annexin V-positive parasites exposing phosphatidylserine on the cell surface 
as compared to untreated controls whereas the plasma membrane integrity was not 
compromised. Importantly, treatment of parasite-infected human fibroblasts with 
staurosporine induced the appearance of TUNEL-positive intracellular parasites, indicating 
that an apoptosis-like cell death can also occur in parasites in their natural intracellular 
environment. 
In our study, we did not find evidence that apoptosis-like cell death contributes to 
the regulation of tachyzoite density during acute infection in the peritoneal cavity of 
infected mice. However, TUNEL-positive parasites were detected in bradyzoite-containing 
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tissue cysts from the brains of chronically infected mice, suggesting that T. gondii 
employed an apoptosis-like cell death during chronic infection. We further investigated 
whether parasites underwent apoptosis under treatment with various drugs commonly used 
for chemotherapy of toxoplasmosis. Parasite replication decreased after treatment with 
anisomycin, pyrimethamine, atovaquone, and clindamycin, as shown by lower numbers of 
parasites per parasitophorous vacuole as compared to the untreated parasites. The number 
of extracellular TUNEL-positive parasites increased after treatment with all drugs. 
Intriguingly, treatment with clindamycin resulted in the emergence of intracellular 
TUNEL-positive parasites, suggesting that drug treatment can also induce an apoptosis-
like phenotype in intracellular T. gondii.  
In order to identify proteins which might play a role in T. gondii PCD, seventeen 
cell death-related genes were identified in the T. gondii genome database. Messenger RNA 
analysis of these genes showed that all of them were expressed in untreated parasites and 
that several of them were strongly up-regulated upon staurosporine treatment. Miltefosine 
treatment led to a more restricted transcriptional response of T. gondii with a putative 
PDCD2 gene again, as in response to staurosporine, being most strongly up-regulated. In 
this project, we focused on T. gondii Bax inhibitors and Endonuclease G, conserved 
proteins which might play roles in ancient PCD pathways. 
In silico analysis of the T. gondii genome demonstrated the presence of putative 
Bax inhibitor genes, named T. gondii Bax inhibitor-1, -2 and -3 (TgBI-1, TgBI-2 and 
TgBI-3). Amino acid sequence analysis of TgBI-1, TgBI-2 and TgBI-3 showed 33-38 % 
identity with human BI-1. Putative TgBI-1, TgBI-2 and TgBI-3 contain 6-9 
transmembrane domains and have a molecular weight of 37,974 Da, 29,322 Da and 37,345 
Da, respectively. To unravel possible functions of TgBIs in the regulation of apoptosis, we 
stably transfected HeLa cells with the genes encoding TgBI-1, TgBI-2 and TgBI-3 and this 
was confirmed by immunofluorescence microscopy. Measurement of caspase 3/7 activity 
demonstrated an inhibitory effect of TgBI-1 and TgBI-2 in HeLa cells after treatment with 
staurosporine and brefeldin A. Moreover, TgBI-1, TgBI-2- and TgBI-3-expressing HeLa 
cells showed a lower induction of hypoploid DNA (subpeak G0/G1) after treatment with 
pro-apoptotic stimuli as above. These results suggested that T. gondii Bax inhibitors might 
fulfill conserved functions in regulating an apoptosis-like cell death in T. gondii. 
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T. gondii Endonuclease G (TgEndoG) shares 31.5 %, 38.1 %, 36.1 % and 35.3 % 
identity with EndoG of Homo sapiens, Mus musculus, Bos taurus and S. cerevisiae 
respectively. Putative TgEndoG consists of 894 amino acids and has a molecular weight of 
96.2 kDa. Using MitoProt analysis, this protein is likely transported into mitochondria. 
However, YFP-tagged endogenous TgEndoG revealed that this protein has a non-
mitochondrial localisation. Nevertheless, our finding on the predicted structure showed a 
conserved active domain of TgEndoG, suggesting that it might show pro-apoptotic 
nuclease activity, possibly being responsible for the occurrence of DNA fragmentation as 
observed in T. gondii following treatment with pro-apoptotic stimuli.  
In order to determine regulation of apoptosis-like cell death in T. gondii, 
MitoTracker staining was used to examine the mitochondrial membrane potential (ΔΨm) 
upon cell death induction. The majority of parasites retained an intact ΔΨm following 
staurosporine treatment. Conversely, miltefosine treatment led to a significant loss of ΔΨm 
in the majority of parasites. Although protozoa do not express genuine caspases, caspase-
like activities have been identified during cell death in other unicellular organisms. Using a 
CaspaTag assay, a method for in situ labelling of active caspase, we observed a rapid and 
strong caspase-like activity in parasites after miltefosine treatment. In contrast, after 
staurosporine treatment, caspase-like activity increased only transiently and to a lower 
extent. Importantly, in the presence of protease inhibitors (E64 and Z-VAD-FMK), the 
emergence of TUNEL-positive parasites was significantly abolished upon miltefosine 
induction, but not staurosporine. 
Taken together, the results indicate the existence of an apoptosis-like cell death 
mechanism in T. gondii which might play a role during chronic infection. Additionally, we 
proof for the first time that treatment of intracellular parasites with the chemotherapeutic 
drug clindamycin induces an apoptosis-like cell death phenotype in a small proportion of 
parasites. Our results on TgBIs indicate evolutionary conserved protective effects of BI 
proteins from T. gondii to mammals and suggest a role of TgBI proteins in regulation of T. 
gondii apoptosis-like cell death. Furthermore, distinct apoptosis-like cell death pathways 
appear to exist in T. gondii; one involves both a loss of ΔΨm and an activation of caspase-
like proteases, which is specifically triggered by miltefosine. Further experiments to 
unravel precise mechanisms of PCD in Toxoplasma are required. A better understanding 
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on Toxoplasma PCD might provide new possibilities to combat the parasite particularly 
during its persistent bradyzoite stage. 
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